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KEY POINTS: 1 
• Endoglin regulatory elements target hemogenic mesoderm and hemogenic 2 
endothelium 3 
• Hemogenic progenitors can be enriched using these elements as molecular probes to 4 
discover novel regulators of hematopoiesis 5 
  6 
3 
 
ABSTRACT  1 
Enhancers are the primary determinants of cell identity and specific promoter/enhancer 2 
combinations of Endoglin (ENG) have been shown to target blood and endothelium in the 3 
embryo.  Here, we generated a series of embryonic stem cell lines, each targeted with reporter 4 
constructs driven by specific promoter/enhancer combinations of ENG, to evaluate their 5 
discriminative potential and value as molecular probes of the corresponding transcriptome.  6 
The Eng promoter (P) in combination with the -8/+7/+9kb enhancers, targeted cells in FLK1 7 
mesoderm that were enriched for blast colony forming potential, whereas the P/-8kb enhancer 8 
targeted TIE2+/c-KIT+/CD41- endothelial cells that were enriched for hematopoietic 9 
potential. These fractions were isolated using reporter expression and their transcriptomes 10 
profiled by RNA-seq. There was high concordance between our signatures and those from 11 
embryos with defects at corresponding stages of hematopoiesis.  Of the six genes that were 12 
up-regulated in both hemogenic mesoderm and hemogenic endothelial fractions targeted by 13 
the reporters, LRP2, a multiligand receptor, was the only gene that had not previously been 14 
associated with hematopoiesis. We show that LRP2 is indeed involved in definitive 15 
hematopoiesis and by doing so validate the use of reporter gene coupled enhancers as probes 16 
to gain insights into transcriptional changes that facilitate cell fate transitions. 17 
 18 




With advances in microscopy and histology, different cell types can now readily be 2 
distinguished from one another.  However, the molecular characteristics that make each cell 3 
type unique and help distinguish stem cells from their more differentiated progeny in a tissue, 4 
are still obscure.  Harvesting pure populations of stem cells is a pre-requisite to probing their 5 
molecular identity. Over the years, protocols combining flow cytometry with single cell serial 6 
transplantation assays have been progressively refined to purify mouse and human adult 7 
hematopoietic stem cells (HSCs)1,2.  8 
 9 
One of the utilitarian benefits of determining the molecular fingerprint of a HSC is 10 
that it could serve as a measurable goal when developing protocols aimed at generating HSCs 11 
from differentiated cells3.  The failure of current protocols to generate long-term repopulating 12 
HSCs from ES/iPS cells is attributed in part to our incomplete understanding of the 13 
developmental journey that mesodermal progenitors traverse in the embryo when generating 14 
the complement of HSCs that are resident in the bone marrow of a newborn4. Determining 15 
the molecular identities of embryonic HSC precursors is complicated by the lack of 16 
consensus regarding the precise HSC intermediates in the embryo, functional assays that are 17 
less than ideal for assessment of these intermediates and knowledge that these intermediates 18 
are transitory cell populations that are present in very small numbers5.  FLK1 expressing 19 
mesodermal cells in the posterior primitive streak when isolated from the embryo and 20 
cultured in vitro generate blast colonies that have blood, endothelial and vascular smooth 21 
muscle potential6. Blast colony forming cell (BL-CFC) potential in FLK1+ mesoderm has 22 
been estimated to be ~1:3007.  Hemogenic potential in TIE2+c-KIT+ hemogenic endothelial 23 
or VE-CAD+CD45-CD41- pre-HSC cells in the dorsal aorta that transit to hematopoietic 24 
cells range from 1:100-300 8-10. These functional estimates are too low to probe the molecular 25 
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identities of either the early hemangioblast or hemogenic endothelial cell populations in the 1 
developing embryo using currently available protocols. 2 
 3 
Cell identity is encoded within the sequences of tissue specific gene regulatory 4 
elements that direct and coordinate gene expression in a cell11.  A number of regulatory 5 
elements of hematopoietic transcription factors have previously been shown to direct reporter 6 
expression to developing blood cells in the mouse embryo and include enhancers of Scl, 7 
Runx1, Gata2, Erg, Fli1, Lmo2 and Lyl1, which also form a recursive circuit in human adult 8 
HSCs12.  The Runx1+23 enhancer marks a population of early hemogenic endothelial cells 9 
that transit to HSCs and has been used to isolate cells from different embryonic stages for 10 
transcriptomic analysis13. Ly6a/Sca1 and Endoglin (Eng; CD105) serve as useful cell surface 11 
markers for isolation of murine HSC fractions14,15. The promoter of Ly6a and 12 
promoter/enhancer combinations of Eng also target embryonic hematopoiesis and in the case 13 
of the former have been used in conjunction with a reporter to isolate hemogenic endothelial 14 
cells and HSCs from early embryos16-18. 15 
 16 
ENG is an accessory receptor and modulator of TGF-β superfamily signaling19.  ENG 17 
is expressed on FLK1+ mesoderm and is required for normal BL-CFC development and its 18 
expression facilitates the hematopoietic program in these cells10,20.  ENG null mice die at 19 
E9.5 with vascular defects due to abnormal endothelial and pericyte development21.  It is also 20 
a marker of adult murine HSCs that was identified using a Scl+19 driven fluorescent reporter 21 
coupled with transcriptomic and proteomic assessment of purified cells15.  An emerging 22 
concept of developmental hematopoiesis posits that HSC development from the dorsal aorta 23 
at E10 reflects maturation of cells that were fated earlier during embryogenesis towards the 24 
hematopoietic lineage13.  As such we rationalised that transcriptional regulation of ENG, 25 
6 
 
which is functionally important for the development of hematopoietic intermediates could be 1 
instructive in helping elucidate the transcriptional environment of these cells. We have 2 
previously shown that sequence information within the promoter and hemato-endothelial 3 
enhancers of Eng determine how reporter genes are targeted to either endothelial or blood and 4 
endothelial tissues in the embryo17,22.  Given the spectrum of cell types that are involved in 5 
the developmental journey of embryonic HSCs and the deterministic role that ENG plays in 6 
their development, we hypothesised that distinct combinations of promoter/enhancers of this 7 
gene are used by different hematopoietic intermediates to regulate ENG expression. We 8 
rationalised that if distinct promoter/enhancer constructs indeed targeted functionally distinct 9 
hematopoietic intermediates, they could be used as molecular probes to profile the 10 
transcriptional environment of these cells. 11 
 12 
Here we show using ES cells with single copy reporter coupled transgenes targeted to 13 
the constitutively active HPRT locus that distinct  promoter/enhancer combinations of ENG 14 
are used by FLK1+ mesoderm and hemogenic endothelium that are enriched for BL-CFC and 15 
hematopoietic potential respectively. Using these reporter coupled transgenes as probes to 16 
harvest cell populations from ESC differentiation assays, we performed RNA-seq to identify 17 
gene sets that were associated with functional enrichment of hematopoietic potential and 18 
show their complementarity with primary mouse tissues at matching stages of development.   19 
Of the six genes that were up-regulated in both hemogenic mesoderm and hemogenic 20 
endothelial fractions targeted by the reporters, LRP2, a multiligand receptor, was the only 21 
gene that had not previously been associated with hematopoiesis. Here, we show that LRP2 is 22 
indeed involved in AGM hematopoiesis and by doing so validate the use of reporter gene 23 
coupled enhancers as a discovery tool. 24 
  25 
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MATERIALS AND METHODS 1 
Murine ES cell culture and Hprt targeting  2 
The Bry/GFP7 and HM1 ES cells23  were cultured as previously described. See Supplemental 3 
data 4 
 5 
ES cell differentiation into EBs and lacZ staining 6 
To generate EBs, ES cells were collected and cultured as detailed in Supplemental data.  7 
 8 
Flow cytometry and cell sorting 9 
Cells were collected from EBs and liquid blast cultures and dissociated into a single cell 10 
suspension. Details of procedure and antibodies are listed in Supplemental data 11 
 12 
Methylcellulose blast colony forming (BL-CFC) assay and liquid cultures 13 
See Supplemental data 14 
 15 
Hematopoietic methylcellulose colony-forming assay 16 
Cells isolated from day 2 or 4 of liquid blast cultures and seeded for CFU-C assays as 17 
detailed in Supplemental data.  18 
 19 
RT-PCR 20 
List of primers and methods are in Supplemental data. 21 
 22 
Chromatin immunoprecipitation (ChIP) assay 23 
ChIP assays were performed as detailed previously22.  See Supplemental data for a list of 24 




Mouse embryo immunostaining and imaging 2 
Details of procedure and antibodies are listed in Supplemental data. 3 
 4 
Generating zebrafish morpholinos and analysis 5 
Details are listed in Supplemental data. 6 
 7 
Statistical analysis 8 
RT-PCR data, BL-CFCs and hematopoietic colony counts were statistically analysed using 9 
Student’s T-test or Paired Student’s T-test.  10 
 11 
RNA sequencing and analysis 12 
The data has been deposited in GEO under the accession number GSE77390. The Ingenuity 13 
IPA Core Analysis Tool (version 17199142) and the GSEA Java Desktop tool (v 2.0.13) were 14 
used for analysis. See Supplemental data for details. 15 




Mesoderm to hemangioblast transition is accompanied by increased Eng expression and 2 
chromatin accessibility at hemato-endothelial regulatory elements.  The promoter of 3 
ENG when coupled with -8kb, +7kb and +9kb enhancers have previously  been shown to 4 
direct reporter expression to either endothelial or blood and endothelial tissues in the embryo 5 
(Figure 1A; 17,22). The Bry-GFP ESC line has been used extensively to investigate the 6 
developmental progression of pre-mesoderm (GFP-/FLK1-) to pre-hemangioblast mesoderm 7 
(GFP+/FLK1-; G+/F-) to the hemangioblast (GFP+/FLK1+; G+F+)7 (Figure 1B).  We used 8 
this cell line to first evaluate expression of Eng and chromatin accessibility at hemato-9 
endothelial regulatory elements of Eng17,22 as cells progressed from pre-hemangioblast 10 
mesoderm to hemangioblast mesoderm.  Eng expression increased by ~ 3-fold (Figure 1C)  11 
and enrichments of H3K9 acetylation (an active chromatin mark) increased  ~ 10-20 fold at 12 
the Eng promoter and -8kb, +7kb and +9kb Eng enhancers (Figure 1D).  There was no 13 
change in H3K9Ac at -4kb, a region that is highly conserved across species but shows no 14 
enhancer activity22.  15 
 16 
The Eng promoter when combined with the -8, +7 and +9 hemato-endothelial 17 
enhancers, targets FLK1+ mesodermal cells enriched for BL-CFC potential.  HM1 ESCs 18 
have a disrupted Hprt locus that can be reconstituted by homologous recombination of a 19 
targeting vector23.  They serve as a useful tool to evaluate reporter activity of single copies of 20 
gene regulatory elements at a constitutively active locus at different stages of ESC 21 
differentiation. We took advantage of this system to introduce combinations of Eng 22 
regulatory elements with blood and endothelial activity in in vivo transgenic assays (Figure 23 
S1). Successful recombination and generation of ESC lines with -8/P/lacZ, -8/P/lacZ/+7, -24 
8/P/lacZ/+9, -8/P/lacZ/+7/+9, -8/P/lacZ/+7Δ (GATA)/+9 and -8/P/lacZ/+7Δ (GATA)/+9 Δ 25 
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(ETS), was confirmed by RT-PCR and southern blotting (Figure S2). We used these ESC 1 
lines as a tool-kit with which to track, evaluate and compare the activity of each of these gene 2 
regulatory elements (GREs) during different stages of hematopoietic development and to 3 
fractionate cells for functional validation and transcriptomic analysis.   4 
  5 
To identify which, if any of the Eng GREs, targeted FLK1+ mesoderm enriched for 6 
hemangioblast potential, we generated embryoid bodies (EBs) from each ESC line and 7 
fractionated FLK1+lacZ- (F+L-) and FLK1+lacZ+ (F+L+) cells and performed blast colony 8 
forming cell (BL-CFC) assays (Figure 2A).  The Eng -8/P/lacZ/+7/+9 construct, which 9 
showed robust blood and endothelial staining in vivo17 targeted a fraction of the FLK1+ 10 
mesoderm that showed increased (~ 4 fold) BL-CFC potential (Figure 2B and Figure S3A). 11 
We have previously shown that mutating the GATA binding motifs in +7 and ETS binding 12 
motifs in +9 diminished endothelial activity and extinguished hematopoietic activity of the 13 
Eng -8/P/lacZ/+7/+9 construct in transgenic assays17. There was a corresponding reduction or 14 
failure of the mutant constructs to preferentially target cells with BL-CFC potential (Figure 15 
2C (i)-(ii) and Figure S3B). The -8P/lacZ construct showed strong endothelial but no 16 
hematopoietic activity in transgenic assays17. FLK1+ cells targeted by this construct (F+L+) 17 
showed significantly lower BL-CFC potential than F+L- cells (Figure 2D (i) and Figure 18 
S3A). For the -8P/lacZ/+7 and -8P/lacZ/+9 constructs, which showed strong endothelial and 19 
low- to moderate hematopoietic activity in in vivo transgenic assays17, FLK1+ mesoderm 20 
(F+L+) had either lower or equivalent BL-CFC activity than FLK1+ (F+L-) cells (Figure 2D 21 
(ii)-(iii) and Figure S3A).    It is important to note that the total number of BL-CFCs 22 
generated by FLK1+ mesoderm will vary from clone to clone but that comparisons are of 23 




 Taken together, these data show that the GREs of ENG that showed increased 1 
chromatin accessibility as pre-hemangioblast mesoderm progressed to hemangioblast 2 
mesoderm (i.e. -8/P/+7/+9; Figure 1D) act collectively to target reporter gene expression to 3 
BL-CFCs in FLK1+ mesoderm.  It is noteworthy that in in vivo transgenic assays, it was also 4 
this construct (-8/P/lacZ/+7/+9) that had the strongest and most specific activity in blood and 5 
endothelium in the developing embryo17. 6 
 7 
Global transcriptomic analysis of FLK1 mesoderm targeted by Eng -8/P/LacZ/+7/+9 8 
identifies genes associated with hemangioblast activity.  To discover genes associated with 9 
the activation of these GREs and increased activity of the reporters, we performed RNA-10 
sequencing on sorted lacZ+ and lacZ- cell fractions from three independent experiments.  As 11 
expected Kdr (Flk1) expression was comparable in both fractions and Eng transcripts were 12 
increased in the lacZ+ fraction consistent with Eng GRE driven reporter activity (Figure 3A).  13 
There was also a shared set of genes that was consistently differentially expressed between 14 
the lacZ+ and lacZ- cell fractions (Figure 3B (i)) and included 107 up-regulated and 101 15 
down-regulated genes.   These included cell surface receptors and transcription factors known 16 
to be associated with blood and endothelium (fold change ≥ 2 and p-value <0.5; Table S1 and 17 
Figure S4A) and genes that have been associated with hemangioblast development in the 18 
LifeMap Sciences embryonic development compendium (Figure 3B (ii)). Individually the 19 
expression of many genes known to be associated with early mesoderm (e.g. Bry/T and 20 
Bmp4), blood (e.g. Gata1 and Tal1) and endothelial (e.g. Foxc2 and Etv2) development did 21 
not vary significantly between these cell fractions (Figure 3B (ii)). Indeed, as hemangioblasts 22 
are a sub-population of FLK1+ mesoderm with multi-lineage differentiation potential, it 23 
would have been unusual to see significant differences in expression of individual genes that 24 
are strongly associated with commitment to a specific lineage.  However, ingenuity pathway 25 
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analysis (IPA) revealed that when differentially expressed genes were considered as a 1 
collective, there were strong associations with blood and blood vessel development for genes 2 
in the FLK1+/lacZ+ set (Figure S4B).  Consistent with these biological functions, this gene 3 
set also showed significant associations with signaling pathways that govern endothelial 4 
development and eNOS signaling (Figure S4C-F). 5 
 6 
To investigate the in vivo relevance of our gene set, we used GSEA analysis to 7 
compare expression overlaps with gene expression data from FLK1+ cells in ETV2 24,25 and 8 
LDB126 KO embryos, both of which are defective in hemangioblasts (Figure 3C). There were 9 
strong overlaps between genes expressed in FLK1+ mesoderm targeted by ENG -10 
8/P/lacZ/+7/+9 and genes expressed in hemangioblast competent WT ETV2 and LDB1 11 
embryos compared to ETV2+/- or LDB1-/- embryos respectively.  Therefore the molecular 12 
signature of BL-CFC enriched FLK1+ mesoderm that was identified using differential 13 
reporter activity of ENG GREs is consistent with in vivo functional capacity. 14 
 15 
The Eng promoter in combination with the -8 endothelial enhancer targets hemogenic 16 
endothelial cells enriched for hematopoietic potential.  Definitive hematopoiesis in the 17 
embryo progresses through a TIE2+/c-KIT+/CD41- hemogenic endothelial (HE) intermediate 18 
9. We used a cell culture system that mirrors this in vivo transition to investigate whether any 19 
of the reporter ESC lines preferentially targeted HE cells and whether they could be used to 20 
isolate cell fractions that were enriched for hematopoietic potential9. To this end, FLK1+ 21 
cells were sorted from day 3EBs and seeded into liquid blast culture media (Figure 4A). At 22 
day 2 of culture, lacZ+ and lacZ- HE cells were isolated by FACS and re-seeded into liquid 23 
blast media (LBM) for two further days followed by flowcytometry and CFU-C assays to 24 
evaluate the hematopoietic potential of each fraction.  Of the reporter ESC lines, Eng -25 
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8/P/lacZ was unique in that it was active in a fraction of HE cells that generated more TIE2-1 
/CD41+ and CD45+ cells after 48 hours in culture (Figure 4B (i)- (ii)) and contained almost 2 
all CFU-C potential (Figure 4B (iii)). Whereas Eng -8/P/lacZ/+7/+9 targeted FLK1+ 3 
mesoderm with increased BL-CFC potential (Figure 2), it did not target HE cells with 4 
increased hematopoietic potential (Figure 4C (i) - (iii)). Indeed this and each of the other 5 
constructs, targeted HE cells that had lower hematopoietic potential (Figure 4D-E; Figure 6 
S5). Taken together, these data showed that not only was there a specific combination of 7 
ENG GREs that targeted HE cells but that the combination was distinct from that which 8 
targeted BL-CFCs in FLK1+ mesoderm. 9 
 10 
Hematopoietic potential is highest in Eng -8/P/lacZ targeted HE cells that do not as yet 11 
express surface ENG. Cell fate transitions are dynamic and our purpose was to use these 12 
reporter constructs to capture HE cells that were intrinsically fated towards the hematopoietic 13 
lineage at the earliest possible time point in culture.  Based on the assumption that there 14 
would be a delay between transactivating the Eng GRE reporter and surface expression of 15 
ENG, we repeated the experiments described in Figure 4 using the Eng -8/P/lacZ ES cell line 16 
but here also incorporating surface ENG expression to isolate TIE2+/C-KIT+/CD41- HE 17 
fractions that were ENG+/lacZ-, ENG+/lacZ+ or ENG-/lacZ+ (Figure 5A).  Interestingly, 18 
CFU-C potential within the lacZ+ fraction was highest in ENG-/lacZ+ HE cells (Figure 5B 19 
(i) – (ii)). ENG+/lacZ-, ENG+/lacZ+ and ENG-/lacZ+ HE cells were re-seeded in LBM and 20 
analysed by flow cytometry and CFU-C assays after two further days of culture.  The 21 
proportions of TIE2-/CD41+ (Figure 5C (i)) and CD45+ (Figure 5C (ii)) cells and CFU-C 22 
potential (Figure 5C (iii)) were highest for cultured ENG-/lacZ+ HE cells.  Taken together, 23 
these data show that the hematopoietic potential within HE cells can be targeted by Eng -24 
14 
 
8/P/lacZ and that these ESCs could be used to interrogate the earliest transcriptional changes 1 
associated with this cell fate decision. 2 
 3 
Transcriptomic analysis of HE fractions identifies genes associated with hemogenic 4 
endothelial to hematopoietic transition.    To discover genes, that act on Eng -8/P/lacZ and 5 
drive reporter gene activity and by extension are associated with hemogenic potential in 6 
TIE2+/C-KIT+/CD41- HE cells, we performed RNA-sequencing on sorted ENG+/lacZ-, 7 
ENG+/lacZ+ and ENG-/lacZ+ HE cell fractions from three independent experiments.  As 8 
expected the fractions, which expressed surface ENG had abundant Eng transcripts, which 9 
were still comparatively low in ENG-/lacZ+ HE cells (Figure 6A). Consistent with its role as 10 
a major determinant of endothelial to hematopoietic transition (EHT)9,27,28,  Runx1 transcripts 11 
were abundant in HE cells that were enriched with functional hemogenic cells (ENG-/lacZ+ 12 
HE) and relatively low in those (ENG+/lacZ- and ENG+/lacZ+ HE) that were not. In total, 13 
there were 707 up-regulated and 981 down-regulated genes in ENG-/lacZ+ HE cells 14 
compared with ENG+/lacZ- and ENG+/lacZ+ HE cells (Figure 6B (i); Table S2). It was 15 
interesting to note that only a subset of genes that have previously been attributed to mark HE 16 
cells based on cell surface protein expression were16 differentially expressed between these 17 
functionally distinct HE sub-populations (Figure 6B (ii)).  This does not imply that these 18 
genes are not important but that their higher or lower expression is not associated with these 19 
early subtle transitions. 20 
 21 
To investigate the in vivo relevance of our gene set, we used GSEA analysis to 22 
compare expression overlaps between ENG-/lacZ+ HE vs. ENG+/lacZ- HE and gene sets 23 
generated from primary embryonic endothelial cell (EC), hemogenic endothelial cells (HECs) 24 
and HSCs16. Consistent with our functional data, the gene sets associated with EC to HE 25 
15 
 
transition (Figure 6C (i) and HE to HSC transition (Figure 6C (ii)) showed strong overlaps 1 
with genes expressed in ENG-/lacZ+ HE.  Gene sets associated with HIF1a and DNA 2 
replication also showed strong overlaps with genes expressed in ENG-/lacZ+ HE cells 3 
(Figure S6A). Genes that were UP in ENG-/lacZ+ HE compared with ENG+/lacZ- HE cells 4 
feature prominently in IPA reconstructions of gene networks governing hematopoietic 5 
development (Figure S6B).  Whereas genes that were UP in ENG-/lacZ+ HE cells compared 6 
with either ENG+/lacZ- HE or ENG+/lacZ+ HE cells were associated with biological 7 
processes relating to blood development, genes that were DOWN in ENG-/lacZ+ HE cells 8 
relative to the other two fractions were associated more with angiogenesis or vasculogenesis 9 
(Figure S6C-E).  Interrogation of differentially expressed transcription factors (TFs) and cell 10 
surface receptors (CSRs) in the more functionally hemogenic ENG-/lacZ+ HE fraction 11 
relative to the ENG+/lacZ- HE fraction showed up-regulation of a number of TFs (e.g. 12 
Runx129, Myb30, Gfi1b31 etc.) and CSRs (Lgr532) that are known to play a role in HSC 13 
development and down regulation of others (e.g. Sox1733), which are important for HE to 14 
HSC transition (Figure 6D). 15 
 16 
Lrp2 is required for normal blood emergence in the zebrafish aorta. We then overlapped 17 
our gene sets to visualise associations between genes that were UP or DOWN in haemogenic 18 
mesoderm (HB) and/or hemogenic endothelium (HE) (Figure S7 and S8; Table S1-S2) to 19 
interrogate their function.   Six genes were shared between the up-regulated groups (Figure 20 
7A; Figure S7C) and eight genes between the down-regulated groups (Figure S8A).  Genes 21 
that were DOWN in both HB and HE cells included several with no known association with 22 
haematopoiesis (Figure S8B).  However, we focused on genes that were UP in both HB and 23 
HE cells (Figure 7A and S7C) for practical considerations given that their expression and 24 
functional role would be easier to validate. This group included hematopoietic transcription 25 
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factors (Gfi1 31 and Lyl134), a platelet protein kinase C substrate (Plek35) and granulocyte 1 
lysosomal and lysosomal membrane proteins (Mpo36 and Laptm537), all of which have known 2 
functions in the hematopoietic system.  It also included a multifunctional ligand (Lrp2) with 3 
no previously described role in blood or blood development. Lrp2/Megalin is a member of an 4 
endocytic receptor complex that is involved in maternal-fetal transport of folate and other 5 
nutrients, lipids and morphogens such as sonic hedgehog (Shh) and retinoids38.  Given these 6 
associations we postulated that Lrp2 up-regulation in blood precursors was likely to be of 7 
functional significance.  8 
 9 
 The Ly6aGFP (Sca1) mouse model, in which all HSCs throughout development are 10 
GFP+14,39 has facilitated the study of EHT. There mice were used to show in real-time, the 11 
transition of morphologically flat endothelial GFP+ cells in the E10.5 aorta to round GFP+ 12 
cells that co-express other HSC markers40.  Given that LRP2 was up-regulated in HE cells, 13 
we evaluated LRP2 expression in Ly6aGFP E10.5 AGM.  LRP2 shows specific expression in 14 
endothelial cells with strong expression in Ly6aGFP+ endothelial cells and hematopoietic 15 
clusters (Figure 7B).   16 
 17 
EHT is an evolutionarily conserved process in vertebrates and real-time imaging of 18 
transgenic zebrafish embryos has also shown the transition of aortic endothelial cells to 19 
hematopoietic cells41,42.  Lrp2 is highly conserved across different vertebrate species (Figure 20 
7C; average sequence identity across all species shown = 70 %).  The zebrafish genome has 21 
two closely related protein- coding genes, lrp2a on chr. 9 and lrp2b on chr. 12, both of which 22 
are expressed at 24-72hpf 43.  To validate the involvement of LRP2 in HSC generation, we 23 
used a zebrafish morpholino oligo (MO) knockdown approach targeting both lrp2a and 2b 24 
together and each alone. At 36h post fertilization (hpf), morphants were assayed by ISH for 25 
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cmyb and runx1, markers for emerging blood progenitors in the aorta44. WT embryos showed 1 
robust cmyb and runx1 expressing cells along the dorsal aorta in contrast to lrp2a/b 2 
morphants that showed severe reductions (Figure 7D (i); Figure S9A). There was partial 3 
rescue of AGM blood progenitors when lrp2a/b morphants were co-injected with hLRP2 4 
mRNA. The partial rescue was probably due to only partial homology of protein sequences 5 
between humans and fish (~ 65%) and quality of in vitro transcribed mRNA given the large 6 
size of LRP2 cDNA (~14kb).  To exclude non-specific toxicity related loss of cmyb and 7 
runx1 expressing cells, we co-injected lrp2a/b MO with tp53 MO and saw no restitution of 8 
cmyb expressing cells in the morphants (Figure S9B).  Injection of lrp2bMO but not 9 
lrp2aMO, reduced the numbers of cmyb expressing AGM blood progenitors (lrp2bMO; 10 
Figure 7D (ii); lrp2a; data not shown).  To establish that this defect in blood cell production 11 
was not a secondary to loss of vascular integrity, we injected lrp2a/b MO into flk:zsgreen 12 
transgenic embryos and saw no difference between morphants and controls at 32 hpf (Figure 13 
7E). In addition to vascular integrity we also assessed blood flow in morphants. Both heart 14 
function as well as blood flow was indistinguishable from control embryos (data not shown). 15 
Taken together these data support a role for LRP2 during AGM hematopoiesis. 16 
  17 
 18 




Regulatory elements of genes that demonstrate tissue specific expression have 2 
previously been used to target and characterise various cell populations in ESC systems45-48.  3 
When initiating these experiments, we did not envisage that distinct combinations of ENG 4 
promoter/enhancers would target haemangioblast potential in FLK1 mesoderm and 5 
hemogenic potential in TIE2+/C-KIT+/CD41- hemogenic endothelium. In retrospect, given 6 
the distinct transcriptomes and functional properties of haemangioblasts and hemogenic 7 
endothelium, this should not have come as a surprise.  Nor did we predict that hemogenic 8 
potential would be enriched in ENG- HE1 cells targeted by the ENG -8PlacZ transgene.  9 
Given that F+L+ cells expressed higher levels of ENG (Figure 3A), these data raise the 10 
question whether HE1 cells emerge from F+L- ENG low cells which are less able than their 11 
F+L+ counterparts to generate BL-CFCs or whether F+L+ ENG high cells subsequently 12 
shutdown ENG expression to facilitate their haemogenic potential in HE1 cells. As these 13 
populations were targeted by different transgenes (F+L+; Eng-8/P/lacZ/+7/+9 and ENG-L+ 14 
HE; Eng-8/P/lacZ), this could not be directly tested. However, ES cells targeted with dual 15 
reporters each driven by either Eng-8/P/+7/+9 or Eng-8/P may assist in addressing this 16 
specific question. 17 
 18 
Lrp2, a gene that encodes megalin, a multiligand uptake receptor that regulates 19 
circulating levels of diverse compounds49 emerged as a novel regulator of hematopoiesis.  20 
Mutations in LRP2 result in impaired neuro-epithelial development and are causative of 21 
Donnai-Barrow and facio-oculo-acoustico-renal syndromes50. It has been implicated in 22 
balancing BMP4 and SHH signaling in neuro-epithelium by acting as a clearance receptor for 23 
BMP4 and by concentrating or depleting SHH by ligand recycling or clearance respectively 24 
in a cell type and context dependent manner51. This is of mechanistic interest as the BMP4-25 
19 
 
SHH gradient between the neural tube and dorsal aorta has also been implicated in the 1 
induction of the HSC developmental program in the ventral wall of the dorsal aorta52.  On a 2 
C57Bl/6N background the LRP2 mutation causes lethality in mice around the time of birth 3 
and there are no mutant pups although embryo collections at all embryonic stages to E18.5 4 
show expected Mendellian ratios. LRP2 mutations on 129 or CD1 backgrounds also do not 5 
yield survivors (Hammes et al, unpublished data). On a FVB/N background however, LRP2 6 
null mice are viable with neural tube defects and this receptor has previously been implicated 7 
in folate endocytosis in the developing neural tube53.  However, peripheral blood and bone 8 
marrow hematopoietic stem and progenitor cell numbers were comparable in FVB/N wild 9 
type and mutant adult mice at 6-9 months of age (Figure S10).  A more detailed analysis of 10 
embryonic hematopoiesis in mutant mice on both C57Bl/6N and FVB/N backgrounds will be 11 
required to establish whether the numbers of emergent HSCs differ at various time points and 12 
the identity of any modifier genes in FVB/N that compensate for the loss of LRP2 and these 13 
investigations are ongoing.  However, taken together with the zebrafish data, which shows 14 
reduction rather than loss of HSCs, LRP2 is likely to facilitate rather than be absolutely 15 
required for EHT.  Indeed, it is important to keep in mind that Lrp2 transcripts were higher in 16 
HB cells with greater BL-CFC potential and HE cells with greater CFU-C potential but cells 17 
with lower numbers of transcripts were also able to generate BL-CFCs and CFU-Cs. 18 
 19 
Deficiency of dietary folate also results in impaired neural tube development and 20 
megaloblastic anemia54. Targeted inactivation of the reduced folate carrier (RFC1), which 21 
facilitates folate delivery into cells results in embryonic lethality at E10.5 due to neural and 22 
hematopoietic defects55 and components of the Megalin complex are amongst the most 23 
significantly disrupted genes in null embryos38.  Coordinated up-regulation of a receptor that 24 
20 
 
facilitates folate uptake in hemogenic endothelial cells would be consistent with demand for 1 
an essential hematinic in cells that are on the threshold of a replicative phase.   2 
 3 
Although we focused our attention on Lrp2, as a gene without a described role in 4 
hematopoiesis, from a list of six that were up-regulated in both hemangioblasts and HE cells, 5 
there were other genes that were UP in only one or the other cell fraction. Given the overlap 6 
of these gene sets with those generated from gene knockout embryos with specific 7 
developmental defects they will serve as a rich resource to explore and manipulate the 8 
emergence of hemangioblasts from FLK1+ mesoderm or hematopoiesis in HE cells. Insights 9 
gained from these manipulations will in turn inform tissue regeneration protocols that aim to 10 
generate functional HSCs. 11 




This work was supported by grants from the National Health and Medical Research Council 2 
of Australia, Australian Research Council and the Dr Tom Bee Stem Cell Research Fund to 3 
JEP,   Cancer Research UK to VK and GL, the BBSRC, Leukaemia and Lymphoma 4 
Research, The Leukaemia and Lymphoma Society, Cancer Research UK, and core support 5 
grants by the Wellcome Trust to the Cambridge Institute for Medical Research and Wellcome 6 
Trust - MRC Cambridge Stem Cell Institute to BG.  7 
 8 
AUTHOR CONTRIBUTIONS 9 
R.N, E.F, P.S, K.K, R.T., M.S., J.K., A.U, J.T, D.B, A.E and R.P performed research and 10 
analysed data. A.S, J.W, A.H, D.K., R.R., T.W., B.G, E.D, and L.Z contributed essential 11 
reagents and advice with data analysis and interpretation.  R.N, G.L, V.K and J.E.P 12 
contributed to study design, data interpretation and manuscript preparation. All authors have 13 
read and approve the manuscript. 14 
 15 
DISCLOSURES 16 
No conflicts of interest to declare. 17 




1. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish 2 
hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-3 
1121. 4 
2. Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE. Isolation of single human hematopoietic 5 
stem cells capable of long-term multilineage engraftment. Science. 2011;333(6039):218-221. 6 
3. Riddell J, Gazit R, Garrison BS, et al. Reprogramming committed murine blood cells to induced 7 
hematopoietic stem cells with defined factors. Cell. 2014;157(3):549-564. 8 
4. Pereira CF, Lemischka IR, Moore K. 'From blood to blood': de-differentiation of hematopoietic 9 
progenitors to stem cells. EMBO J. 2014;33(14):1511-1513. 10 
5. Medvinsky A, Rybtsov S, Taoudi S. Embryonic origin of the adult hematopoietic system: advances and 11 
questions. Development. 2011;138(6):1017-1031. 12 
6. Huber TL, Kouskoff V, Fehling HJ, Palis J, Keller G. Haemangioblast commitment is initiated in the 13 
primitive streak of the mouse embryo. Nature. 2004;432(7017):625-630. 14 
7. Fehling HJ, Lacaud G, Kubo A, et al. Tracking mesoderm induction and its specification to the 15 
hemangioblast during embryonic stem cell differentiation. Development. 2003;130(17):4217-4227. 16 
8. Rybtsov S, Sobiesiak M, Taoudi S, et al. Hierarchical organization and early hematopoietic 17 
specification of the developing HSC lineage in the AGM region. J Exp Med. 2011;208(6):1305-1315. 18 
9. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G. The haemangioblast 19 
generates haematopoietic cells through a haemogenic endothelium stage. Nature. 2009;457(7231):892-895. 20 
10. Nasrallah R, Knezevic K, Thai T, et al. Endoglin potentiates nitric oxide synthesis to enhance definitive 21 
hematopoiesis. Biol Open. 2015;4(7):819-829. 22 
11. Davidson EH. The regulatory genome : gene regulatory networks in development and evolution. 23 
Amsterdam ; London: Elsevier/Academic Press; 2006. 24 
12. Beck D, Thoms JA, Perera D, et al. Genome-wide analysis of transcriptional regulators in human 25 
HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood. 2013;122(14):e12-22. 26 
13. Swiers G, Baumann C, O'Rourke J, et al. Early dynamic fate changes in haemogenic endothelium 27 
characterized at the single-cell level. Nat Commun. 2013;4:2924. 28 
14. Ma X, Robin C, Ottersbach K, Dzierzak E. The Ly-6A (Sca-1) GFP transgene is expressed in all adult 29 
mouse hematopoietic stem cells. Stem Cells. 2002;20(6):514-521. 30 
15. Chen CZ, Li M, de Graaf D, et al. Identification of endoglin as a functional marker that defines long-31 
term repopulating hematopoietic stem cells. Proc Natl Acad Sci U S A. 2002;99(24):15468-15473. 32 
16. Solaimani Kartalaei P, Yamada-Inagawa T, Vink CS, et al. Whole-transcriptome analysis of 33 
endothelial to hematopoietic stem cell transition reveals a requirement for Gpr56 in HSC generation. J Exp Med. 34 
2015;212(1):93-106. 35 
17. Pimanda JE, Chan WY, Wilson NK, et al. Endoglin expression in blood and endothelium is 36 
differentially regulated by modular assembly of the Ets/Gata hemangioblast code. Blood. 2008;112(12):4512-37 
4522. 38 
18. Pimanda JE, Gottgens B. Gene regulatory networks governing haematopoietic stem cell development 39 
and identity. Int J Dev Biol. 2010;54(6-7):1201-1211. 40 
19. Cheifetz S, Bellon T, Cales C, et al. Endoglin is a component of the transforming growth factor-beta 41 
receptor system in human endothelial cells. J Biol Chem. 1992;267(27):19027-19030. 42 
20. Perlingeiro RC. Endoglin is required for hemangioblast and early hematopoietic development. 43 
Development. 2007;134(16):3041-3048. 44 
21. Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science. 45 
1999;284(5419):1534-1537. 46 
22. Pimanda JE, Chan WY, Donaldson IJ, Bowen M, Green AR, Gottgens B. Endoglin expression in the 47 
endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer. Blood. 48 
2006;107(12):4737-4745. 49 
23. Magin TM, McWhir J, Melton DW. A new mouse embryonic stem cell line with good germ line 50 
contribution and gene targeting frequency. Nucleic Acids Res. 1992;20(14):3795-3796. 51 
24. Wareing S, Mazan A, Pearson S, Gottgens B, Lacaud G, Kouskoff V. The Flk1-Cre-mediated deletion 52 
of ETV2 defines its narrow temporal requirement during embryonic hematopoietic development. Stem Cells. 53 
2012;30(7):1521-1531. 54 
25. Kataoka H, Hayashi M, Nakagawa R, et al. Etv2/ER71 induces vascular mesoderm from 55 
Flk1+PDGFRalpha+ primitive mesoderm. Blood. 2011;118(26):6975-6986. 56 
26. Mylona A, Andrieu-Soler C, Thongjuea S, et al. Genome-wide analysis shows that Ldb1 controls 57 
essential hematopoietic genes/pathways in mouse early development and reveals novel players in hematopoiesis. 58 
Blood. 2013;121(15):2902-2913. 59 
23 
 
27. Sroczynska P, Lancrin C, Kouskoff V, Lacaud G. The differential activities of Runx1 promoters define 1 
milestones during embryonic hematopoiesis. Blood. 2009;114(26):5279-5289. 2 
28. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. Runx1 is required for the endothelial to 3 
haematopoietic cell transition but not thereafter. Nature. 2009;457(7231):887-891. 4 
29. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple 5 
chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 6 
1996;84(2):321-330. 7 
30. Mucenski ML, McLain K, Kier AB, et al. A functional c-myb gene is required for normal murine fetal 8 
hepatic hematopoiesis. Cell. 1991;65(4):677-689. 9 
31. Lancrin C, Mazan M, Stefanska M, et al. GFI1 and GFI1B control the loss of endothelial identity of 10 
hemogenic endothelium during hematopoietic commitment. Blood. 2012;120(2):314-322. 11 
32. Liu D, He XC, Qian P, et al. Leucine-rich repeat-containing G-protein-coupled Receptor 5 marks short-12 
term hematopoietic stem and progenitor cells during mouse embryonic development. J Biol Chem. 13 
2014;289(34):23809-23816. 14 
33. Lizama CO, Hawkins JS, Schmitt CE, et al. Repression of arterial genes in hemogenic endothelium is 15 
sufficient for haematopoietic fate acquisition. Nat Commun. 2015;6:7739. 16 
34. Capron C, Lecluse Y, Kaushik AL, et al. The SCL relative LYL-1 is required for fetal and adult 17 
hematopoietic stem cell function and B-cell differentiation. Blood. 2006;107(12):4678-4686. 18 
35. Wehrspaun CC, Haerty W, Ponting CP. Microglia recapitulate a hematopoietic master regulator 19 
network in the aging human frontal cortex. Neurobiol Aging. 2015;36(8):2443 e2449-2443 e2420. 20 
36. Le Guyader D, Redd MJ, Colucci-Guyon E, et al. Origins and unconventional behavior of neutrophils 21 
in developing zebrafish. Blood. 2008;111(1):132-141. 22 
37. Adra CN, Zhu S, Ko JL, et al. LAPTM5: a novel lysosomal-associated multispanning membrane 23 
protein preferentially expressed in hematopoietic cells. Genomics. 1996;35(2):328-337. 24 
38. Gelineau-van Waes J, Maddox JR, Smith LM, et al. Microarray analysis of E9.5 reduced folate carrier 25 
(RFC1; Slc19a1) knockout embryos reveals altered expression of genes in the cubilin-megalin multiligand 26 
endocytic receptor complex. BMC Genomics. 2008;9:156. 27 
39. de Bruijn MF, Ma X, Robin C, Ottersbach K, Sanchez MJ, Dzierzak E. Hematopoietic stem cells 28 
localize to the endothelial cell layer in the midgestation mouse aorta. Immunity. 2002;16(5):673-683. 29 
40. Boisset JC, van Cappellen W, Andrieu-Soler C, Galjart N, Dzierzak E, Robin C. In vivo imaging of 30 
haematopoietic cells emerging from the mouse aortic endothelium. Nature. 2010;464(7285):116-120. 31 
41. Bertrand JY, Chi NC, Santoso B, Teng S, Stainier DY, Traver D. Haematopoietic stem cells derive 32 
directly from aortic endothelium during development. Nature. 2010;464(7285):108-111. 33 
42. Kissa K, Herbomel P. Blood stem cells emerge from aortic endothelium by a novel type of cell 34 
transition. Nature. 2010;464(7285):112-115. 35 
43. Kur E, Christa A, Veth KN, et al. Loss of Lrp2 in zebrafish disrupts pronephric tubular clearance but 36 
not forebrain development. Dev Dyn. 2011;240(6):1567-1577. 37 
44. Jing L, Zon LI. Zebrafish as a model for normal and malignant hematopoiesis. Dis Model Mech. 38 
2011;4(4):433-438. 39 
45. Ferreira R, Spensberger D, Silber Y, et al. Impaired in vitro erythropoiesis following deletion of the Scl 40 
(Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression. Mol Cell 41 
Biol. 2013;33(6):1254-1266. 42 
46. Wu SM, Fujiwara Y, Cibulsky SM, et al. Developmental origin of a bipotential myocardial and smooth 43 
muscle cell precursor in the mammalian heart. Cell. 2006;127(6):1137-1150. 44 
47. Holtzinger A, Rosenfeld GE, Evans T. Gata4 directs development of cardiac-inducing endoderm from 45 
ES cells. Dev Biol. 2010;337(1):63-73. 46 
48. Feng G, Mellor RH, Bernstein M, et al. Imaging neuronal subsets in transgenic mice expressing 47 
multiple spectral variants of GFP. Neuron. 2000;28(1):41-51. 48 
49. Saito A, Pietromonaco S, Loo AK, Farquhar MG. Complete cloning and sequencing of rat 49 
gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci 50 
U S A. 1994;91(21):9725-9729. 51 
50. Kantarci S, Al-Gazali L, Hill RS, et al. Mutations in LRP2, which encodes the multiligand receptor 52 
megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat Genet. 2007;39(8):957-959. 53 
51. Christ A, Christa A, Klippert J, et al. LRP2 Acts as SHH Clearance Receptor to Protect the Retinal 54 
Margin from Mitogenic Stimuli. Dev Cell. 2015;35(1):36-48. 55 
52. Wilkinson RN, Pouget C, Gering M, et al. Hedgehog and Bmp polarize hematopoietic stem cell 56 
emergence in the zebrafish dorsal aorta. Dev Cell. 2009;16(6):909-916. 57 
53. Kur E, Mecklenburg N, Cabrera RM, Willnow TE, Hammes A. LRP2 mediates folate uptake in the 58 
developing neural tube. J Cell Sci. 2014;127(Pt 10):2261-2268. 59 
24 
 
54. Bills ND, Koury MJ, Clifford AJ, Dessypris EN. Ineffective hematopoiesis in folate-deficient mice. 1 
Blood. 1992;79(9):2273-2280. 2 
55. Gelineau-van Waes J, Heller S, Bauer LK, et al. Embryonic development in the reduced folate carrier 3 
knockout mouse is modulated by maternal folate supplementation. Birth Defects Res A Clin Mol Teratol. 4 
2008;82(7):494-507. 5 
 6 
  7 
25 
 
FIGURE LEGENDS 1 
FIGURE 1. Mesoderm to hemangioblast transition is accompanied by increased Eng 2 
expression and chromatin accessibility at hemato-endothelial regulatory elements. (A) 3 
Schematic representation of the ENG locus. The transcription start site is marked with an 4 
arrow. The -8kb, +7kb and +9kb enhancers and the promoter (P) are marked in orange, exons 5 
are marked in brown and the 5’UTR in cyan. (B) Schematic representation of Bry-GFP ES 6 
cell differentiation. At day 3 of EB differentiation, Bry-GFP+/FLK1- (G+F-) and Bry-7 
GFP+/FLK1+ (G+F+) cells were sorted and analysed by RT-PCR and ChIP.  (C) Bar graph 8 
showing Eng mRNA expression levels in sorted FLK1+ve and –ve mesodermal cell 9 
populations in day 3 EBs generated from Bry-GFP ES cells. (D)  A bar graph showing levels 10 
of enrichment of the active chromatin mark, H3K9Ac at Eng -8, P, +7 and +9 hemato-11 
endothelial enhancers relative to IgG in pre-hemangioblast mesoderm (G+F-; black) and in 12 
hemangioblast mesoderm (G+F+; gray).  Eng -4 was included as a negative control region. 13 
**; P < 0.01, ***; p < 0.001 14 
 15 
FIGURE 2.  The Eng promoter when combined with the -8, +7 and +9 haemato-16 
endothelial enhancers targets FLK1+ mesodermal cells enriched for BL-CFC potential. 17 
(A) Schematic representation of the experimental procedure. The Eng -8/P/LacZ, Eng -18 
8/P/LacZ/+7, Eng -8/P/LacZ/+9, Eng -8/P/LacZ/+7/+9, Eng -8/P/LacZ/+7Δ/+9, and Eng -19 
8/P/LacZ/+7Δ/+9Δ reporter constructs were introduced by homologous recombination into 20 
the HPRT locus of HM1 ES cells.  Recombinant clones were differentiated into day 3 EBs 21 
and stained for FLK1 expression and β-galactosidase activity. FLK1+/LacZ- (F+/L-; gray) 22 
and FLK1+/LacZ+ (F+/L+; blue) cells were sorted and seeded into BL-CFC assays. Fractions 23 
sorted from the Eng -8/P/LacZ/+7/+9 were further analysed by RNA-sequencing. (B) Flow 24 
cytometry profiles of Eng -8/P/LacZ/+7/+9 day 3 EBs (left). BL-CFCs from sorted F+/L- 25 
26 
 
(gray) and F+/L+ (blue) fractions. (C) (i) Flow cytometry profile of day 3 EBs derived from 1 
ES cells targeted with Eng -8/P/LacZ/+7Δ /+9 (mutated GATA motifs in the +7 enhancer) is 2 
shown to the left with corresponding BL-CFCs from sorted F+/L- (gray) and F+/L+ (blue) 3 
fractions shown to the right. (ii) Flow cytometry profile of day 3 EBs derived from ES cells 4 
targeted with Eng -8/P/LacZ/+7Δ /+9Δ (mutated GATA motifs in the +7 enhancer and 5 
mutated ETS motifs in the +9 enhancer) and corresponding BL-CFCs from sorted F+/L- 6 
(gray) and F+/L+ (blue) fractions.  (D) Flow cytometry profiles of day 3 EBs and BL-CFCs 7 
from sorted F+/L- (gray) and F+/L+ (blue) fractions are shown for ES cells targeted with (i) 8 
Eng -8/P/LacZ (ii) Eng -8/P/LacZ/+9 and (iii) Eng -8/P/LacZ/+7. BL-CFC counts are the 9 
total number of blast colonies generated from 2x104 seeded cells. Statistical analysis was 10 
using students T-test, *p<0.05, **p< 0.01. 11 
 12 
FIGURE 3. RNA-sequencing of FLK1 mesoderm targeted by Eng -8/P/LacZ/+7/+9 13 
identifies genes associated with hemangioblast activity. (A) RNA-sequencing profiles 14 
showing Kdr (Flk1) transcripts (top panel) and Eng transcripts (bottom panel) in the F+/L- 15 
and F+/L+ fractions. FPKM expression values are shown to the right. (B) (i) Heat map 16 
representation of up- and down-regulated genes in FLK1+/LacZ- (F+/L-) and FLK1+/LacZ+ 17 
(F+/L+) fractions in three independent experiments. (ii) Expression (FPKM values) levels of 18 
genes that have previously been associated with hemangioblast function. The left panel 19 
shows a subset of genes that are differentially expressed between F+/L- and F+/L+ fractions 20 
and the right panel shows a subset of genes that are not.  (C) GSEA profiles showing the 21 
correspondence of genes that are differentially expressed between F+/L- and F+/L+ fractions 22 
and  those that are differentially expressed in ETV2+/- vs. ETV2-/- (top panel) and LDB wt 23 




FIGURE 4. The Eng promoter in combination with the -8 endothelial enhancer targets 1 
hemogenic endothelial cells enriched for hematopoietic potential. (A) Schematic diagram 2 
outlining the experimental procedure.  Recombinant ES cells generated using the Eng 3 
reporter constructs were differentiated into day 3 EBs. FLK1+ mesodermal cells were sorted 4 
from representative clones for each recombinant ES cell line and cultured in liquid blast 5 
media. At 48 hours, CD41-/TIE2+/c-KIT+ (HE) cells were sorted into lacZ+ and lacZ– 6 
fractions. The sorted fractions were re-cultured in liquid blast media for a further 48 hours 7 
followed by flow cytometry and CFU-C assays. (B) (i) CD41 and TIE2 expression in sorted  8 
c-KIT+ HE LacZ- (white) and LacZ+ (blue) fractions (after 2 days of re-culture) derived 9 
from Eng -8/P/LacZ ES cells. (ii) Percentage of CD45+ cells generated from LacZ- and 10 
LacZ+ HE fractions. (iii) Bar chart showing the number and type of hematopoietic colonies 11 
generated by each fraction.  (C) (i)-(iii) Corresponding data to (B) generated from Eng -12 
8/P/LacZ/+7/+9 ES cells. (D) (i)-(iii) Corresponding data to (B) generated from Eng -13 
8/P/LacZ/+7 ES cells. (E) (i)-(iii) Corresponding data to (B) generated from Eng -14 
8/P/LacZ/+9 ES cells.  Primitive and definitive colonies were scored after four and nine days 15 
respectively. Statistical analysis was using students T-test, *; p<0.05, **; p< 0.01. 16 
 17 
FIGURE 5. Hematopoietic potential is highest in Eng -8/P/lacZ targeted HE cells that 18 
do not express surface ENG.  (A) Schematic diagram outlining the experimental procedure.  19 
FLK1+ mesodermal cells were sorted from day 3 EBs generated from the Eng -8/P/LacZ 20 
recombinant ES cell line and cultured in liquid blast culture media. At 48 hours, CD41-21 
/TIE2+/c-KIT+ (HE) cells were sorted into ENG+/LacZ-, ENG+/LacZ+, and ENG-/LacZ+ 22 
fractions. These fractions were either directly seeded into CFU-C assays (B) or re-cultured in 23 
liquid blast media for a further 48 hours and analysed by flow cytometry and CFU-C assays 24 
(C). (B) (i)- (ii) Flow cytometry to show the frequencies of CD41-/TIE2+/c-KIT+ (HE) cells 25 
28 
 
in  ENG+/lacZ+, ENG+/lacZ- and ENG-lacZ+ fractions. (iii) CFU-C potential of each sorted 1 
fractions in (i). (C) (i) Flow cytometry analysis of CD41 and TIE2 expression in sorted HE 2 
cell fractions after two days of re-culture in liquid blast media. (ii)  Bar chart showing the 3 
percentage of CD45 positive cells in sorted fraction. (iii)  Bar chart showing hematopoietic 4 
colony numbers from each fraction.  Primitive and definitive colonies were scored after four 5 
and nine days respectively. Statistical analysis was using student T-test, *; p < 0.05, **; p 6 
<0.01 and ***; p <0.001. 7 
 8 
FIGURE 6. Transcriptomic analysis of HE fractions identifies genes associated with 9 
hemogenic endothelial to hematopoietic transition.  (A) RNA-sequencing profiles showing 10 
Eng transcripts (top panel) and  Runx1 transcripts (bottom panel) in the E+/L-, E+/L+ and E-11 
/L+ fractions. FPKM expression values are shown to the right. (B) (i) Heat map 12 
representation of up- and down-regulated genes in ENG+/LacZ- (E+/L-) HE, ENG+/LacZ+ 13 
(E+/L+) HE and ENG-/LacZ+ (E-/L+) HE fractions in three independent experiments. (ii) 14 
Expression (FPKM values) levels of genes that have previously been associated with 15 
hemogenic endothelium. The top panel shows a subset of genes that are differentially 16 
expressed between E+/L-, E+/L+ and E-/L+ fractions and the bottom panel shows a subset of 17 
genes that are not.  (C) GSEA profiles showing the correspondence of genes that are 18 
differentially expressed between the E+/L-, E+/L+ and E-/L+ fractions and  those that are 19 
differentially expressed in endothelial cells (EC) vs. hemogenic endothelial cells (HEC) (top 20 
panel) and HECs vs. hematopoietic stem cells (HSC) gene sets.  (D) Transcription factors and 21 
cell surface receptors that are up- and down regulated in the Eng -8/P E-/L+ HE fraction. The 22 
log fold changes (logFC) and log false discovery rates (logFDR) are listed for each gene. 23 




FIGURE 7. Lrp2 is required for normal definitive hematopoiesis. (A) Venn diagram 1 
showing the overlap of genes that are UP in FLK1 mesoderm enriched for BL-CFCs and/or 2 
HE cells enriched for hemogenic potential.  (B) Immunohistochemistry of 3 
E10.5 Ly6aGFP AGM shows co-expression of GFP and LRP2 in endothelial cells and 4 
hematopoietic clusters.  The insets show the same sections at low magnification. (C) 5 
Homology relationships of zebrafish lrp2a and lrp2b coding sequences with that of Lrp2 in 6 
different vertebrate species.  (D) ISH for the HSC marker cmyb in zebrafish at 36 hpf. (i) 7 
Low (left-side panels) and high (right-side panels) magnification images of control zebrafish 8 
(top row), lrp2 a/b morpholinos (middle row) and lrp2a/b morpholinos co-injected with 9 
hLRP2 mRNA (bottom row) zebrafish. (ii) Low (left-side panels) and high (right-side panels) 10 
magnification images of control zebrafish (top row) and lrp2b morpholinos. (E) Confocal 11 
images of flk:zsgreen reporter embryos show an intact vasculature in both control (upper 12 
panel) and lrp2a/b morphant (lower panel) embryos. DA; dorsal aorta, NC; notochord, NT; 13 










Murine ES cell culture  
The Bry/GFP 1 and HM1 ES cells 2  have been previously described. Murine ES cells were 
seeded on 6-well plates coated with irradiated mouse embryonic feeders, in media composed 
of 84% Dulbecco's Modified Eagle Medium (DMEM, PAA Laboratories), 15% Fetal Bovine 
serum (FBS, Invitrogen) pre-tested for maintenance of ES cells, 0.1% of 0.15M dilution of 
monothioglycerol (MTG, Sigma Aldrich) and 1000units/ml mouse recombinant Leukaemia 
inhibitory factor (Esgro, Millipore).  
 
 
Generating Hprt targeting constructs 
To generate the Hprt targeting constructs DNA fragments corresponding to the Eng -8, P, +7, 
+9 3,4, mutant +7 (+7Δ, mutant Gata), and mutant +9 (+9Δ, mutant Ets) regions (Fig. S1B) 
along with the LacZ reporter gene were ligated in multiple combinations into the pMP8 
targeting vector. The DNA constructs cloned into pMP8 were sequenced using the following 
primers; Pmp8_F, 5’-AGAACGTCAGTAGTCATAG-3’; Pmp8_R, 5’-
TGCAGTGAGCCAGACTGTG-3’. The generated targeting constructs are listed in 
supplementary figure S1C. A map for Eng -8/P in pMP8 can be found in Supplementary Fig. 
S2A (All other reporter constructs were cloned into the same region of the pMP8 vector).  
 
 
Hprt targeting of HM1 ES cells 
To prepare the cells for targeting, HM1 ES cells were cultured in DMEM-ES medium 
containing 1× 6-Thioguanine (6-TG, Sigma Aldrich) for a week before electroporation.  The 
cells were grown to confluence, washed with PBS, and trypsinized to obtain a single cell 
suspension.  1×108 HM1 cells were resuspended in 900µl ice-cold PBS, mixed with 100µg of 
Pme1-linearized targeting vector and electroporated at 0.8Kv/3uF using a Gene Pulser 
(BioRad). Cells were centrifuged and the pellet was resuspended and distributed over 
4x100mm gelatin-coated plates.  24 hours later, Hypoxanthine Aminopterin Thymidine 
(HAT, Sigma Aldrich-Aldrich) was added to the culture medium to select cells with 
successful integration of the targeting vector.  After 7-10 days, over which the selection 
media was changed every 48 hours, HAT resistant colonies were picked into 96-well plates, 
and maintained in ES medium supplemented with Hypoxanthine-Thymidine (1×HT, Sigma 
Aldrich).  Genomic DNA was extracted and analysed for successful recombination by PCR 
and southern blots. 
 
 
Isolation of Genomic DNA 
Cell pellets were lysed in 500µl of ES cell lysis buffer (10mM Tris pH7.4, 10mM EDTA, 
10mM NaCl, and 0.5% Sarkosyl at 30% stock concentration) with freshly added 1mg/ml 
Proteinase K (20mg/ml stock) and incubated at 55°C O/N. Two phenol chloroform (Sigma 
Aldrich) extractions were performed using the Maxtract low density tubes (Qiagen) 
according to manufacturer’s instructions. Cleanup of the genomic DNA was done by ethanol 
precipitation. The DNA pellet was washed with 70% ethanol, re-suspended in milliQ water 
and stored at -20. Genomic DNA isolated from recombinant ES cell clones was analysed for 
successful integration of the DNA fragments by qPCR using the following primers: LacZ_F, 
5’-GCCATTGTCAGACATGTATAC-3’; LacZ_R, 5’-CTCAACCCTATAGCTCCAG-3’; 
Hprt exon2_F, 5’-GAACCAGGTTATGACCTAGA-3’; Hprt exon2_R, 5’-
ATTGTGGCCCTCTGTGTGCT-3’ (Fig. S2B-D). 
 
Southern blotting 
10µg of genomic DNA was digested with Hpa1 and Sac1 (NEB) at 37°C O/N. The DNA was 
separated on a 0.8% agarose gel (1xSYBR safe DNA stain, Invitrogen), run at 25V for 12-14 
hours. The gel was subsequently washed with 0.25M HCl solution for 20min, and 0.4M 
NaOH for 30min. The DNA was then transferred O/N onto a Hybond membrane (Hybond-
XL, Amersham) in a 0.4M NaOH solution. The membrane was washed in 0.4M NaOH for 
10min, and 2xSSC for 10min. The membrane was then baked in an oven at 85°C for 2 hours 
to crosslink the DNA followed by incubation in a bottle containing 20ml of hybridisation 
buffer (0.5M NaP, 7% SDS, 1mM EDTA, and 1% crystalline grade BSA) for 2 hours at 
65°C. During this time, the probe was labelled with alpha 32P-dCTP (PerkinElmer) using a 
Decaprime II kit (Applied biosystems), as per manufacturers description. The membrane was 
incubated with the labelled probe at 65°C O/N. Membranes were subsequently washed in 
2xSSC at room temperature for 20min, then 0.1xSSC/0.1%SDS preheated to 65°C for 10min. 
The washed membranes were then developed using a phosphoimager.  
 
ES cell differentiation into EBs 
To generate EBs, ES cells were collected and cultured in media consisting of IMDM 
supplemented with 15% FBS (PAA laboratories) pretested for efficient embryonic stem cell 
differentiation, 1% L-Glutamine (Invitrogen), 1% penicillin-streptomycin, 0.3% of 0.15M 
MTG, 0.6% of 30mg/ml transferrin (Life Technologies) and 1% of 5mg/ml ascorbic acid 
(Sigma Aldrich). Cells were then seeded on ultra-low attachment 60mm plates (Sterilin) and 
placed in an incubator at 37°C and 5%CO2. These culture conditions were optimal for growth 
of day 1-4 EBs 5. 
 
LacZ staining  
Fluorescein di-β-D-galactopyranoside (FDG, Sigma Aldrich) is a substrate for β-D-
galactosidase enzyme that is encoded by the LacZ reporter gene. FDG powder was 
reconstituted to a 2mM stock solution according to manufacturer’s instructions. Cells 
collected from day 3EB and D2 liquid blast cultures were dissociated and diluted in PBS/2% 
FBS at a concentration of 3x106 cells/0.1ml. On a 37C heat block, FDG was added to the 
cells at a 1:1 ratio and incubated at 37C for 1 min. The cell suspension was then added to 
IMDM/20%FBS and placed on ice for 1 hour. Further staining with primary and secondary 
antibodies was performed after the LacZ staining procedure.  
 
Flow cytometry and cell sorting 
Cells were collected from EBs and liquid blast cultures and dissociated into a single cell 
suspension. Cells were incubated on ice for 30 min either with a biotinylated or flurochrome-
conjugated primary antibody. For cells stained with a primary biotinylated antibody this was 
followed with 30min incubation with SA-pecy7 secondary antibody. Dead cells were 
excluded from the analysis on the basis of Hoechst 33258 uptake (1µg/ml final concentration; 
Invitrogen). The following primary and secondary antibodies were used for staining; TIE2-
biotin, TIE2-PE, Endoglin-Biotin, Endoglin-PE, CD117-eFluor780, FLK1-APC, FLK1-
Biotin, FLK1-PE, CD41-Biotin, CD41-pecy7, CD41-APC, CD45-percp_cy5.5, CD144-
AlexaFluor647, rabbit anti-mouse Lrp2-pecy7 (Bioss antibodies), streptavidin-pecy7 
(eBiosciences), and anti-rabbit Alexa Fluor-647 (Invitrogen). Flow cytometry analysis was 
performed using standard flow cytometers; LSR or BD Canto II. FACS was performed on an 
Aria II, Influx or Jazz BD.  
 
Methylcellulose blast colony forming (BL-CFC) assay  
2x104 FLK1+/LacZ- and FLK1+/LacZ+ cells sorted from day 3 EBs were seeded in 
methylcellulose mix which consisted of IMDM supplemented with 55% methylcellulose 
(BioScientific), 10% FBS pretested for efficient EB differentiation, 1% L-glutamine, 1% L-
glutamine, 0.6% of 30mg/ml transferrin, 0.3% of 0.15M MTG, 0.5% of 5mg/ml ascorbic 
acid, 15% D4T conditioned media, 0.1% of 5µg/ml VEGF, and 0.1% of 10µg/ml IL-6. A 1ml 
syringe and 18 gauge blunt-end needle were used to aspirate the methylcellulose mix onto 
35mm petri dishes. The blast potential in Flk1+ cells was assayed in triplicate dishes of 1ml. 
The plates were then placed in a humidified incubator 37°C and 5% CO2. Colonies were 
scored following four days of culture 5. 
 
Liquid BL-CFC assay 
Day 3 EBs were dissociated into single cells using trypsin (Gibco), and stained with a Flk1-
PE or Flk1-bio antibody (eBiosciences). Sorted FLK1+ cells were seeded on gelatin coated 
plates at a density of 7.5-8.5x104 cells/9.6cm2 (in a humidified incubator 37°C, 5% CO2). The 
culture medium consisted of IMDM supplemented with 10% FBS pre-tested for 
differentiation, 1% L-Glutamine, 0.6% of 30mg/ml transferrin, 0.3% of 0.15M MTG, 0.5% of 
5mg/ml ascorbic acid, 15% D4T conditioned medium, 0.1% of 5µg/ml VEGF, and 0.1% of 
10µg/ml IL-6 (R&D systems).  
 
Hematopoietic methylcellulose colony-forming assay 
Cells isolated from day 2 or 4 of liquid blast cultures were seeded in media containing IMDM 
supplemented with 55% methylcellulose, 15% plasma derived serum (PDS, Animal 
Technologies), 10% protein-free hybridoma medium (PFHMII, Invitrogen), 1% L-Glutamine, 
0.6% of 30mg/ml transferrin, 0.3% of 0.15M MTG, 0.5% of 5mg/ml ascorbic acid, 1% of 
10µg/ml kit ligand (KL), 0.1% of 1µg/ml IL-3, 0.3% of 10µg/ml G-CSF, 0.1% of 5µg/ml IL-
11, 0.2% erythropoietin at 2000 units/ml, 0.2% of 5µg/ml IL-6, 0.1% of 5µg/ml TPO, and 
0.1% of 10µg/ml GM-CSF. Cells were seeded at a concentration of 3x104cells/ml, and the 
assay was set up in triplicate dishes of 1ml. Primitive colonies were scored after 4-5 days of 
culture, whereas most definitive colonies were scored after 7-10 days. All cytokines used in 
this assay were purchased from R&D systems 5. 
 
RT-PCR 
Prior to RNA isolation from samples, all equipment was treated with RNaseZap (Ambion) to 
remove any contaminating RNases. RNA was extracted using and RNeasy extraction kit 
(Qiagen) following manufacturer’s instructions. RNA was eluted with 30µl RNase-free 
water. cDNA was then synthesized using the GoScript Reverse Transcriptase (Promega) 
following manufacturer’s guidelines.  The cDNA was analysed for expression using the 
Express SYBR Green QPCR Supermix universal (Life Technologies). List of primers used 
for RT-PCR: Eng_F, 5’-AAATCCCGTTGCACTTGG-3’; Eng_R, 5’-
ACTCTTGGCTGTCCTTGGAA-3’; B-actin_F, 5’-TGACAGGATGCAGAAGAAGA-3’; B-
actin_R, 5’-CGCTCAGGAGGAGCAATG-3’; Lrp2_F; Lrp2_R. 
 
Chromatin immunoprecipitation (ChIP) assay 
ChIP assays were performed as detailed previously3.  Briefly, FACS sorted Bry-GFP ES cells 
(+/+ and +/− cell fractions) were treated with 0.4% formaldehyde (Sigma Aldrich) and the 
cross-linked chromatin was retrieved by nuclei isolation and lysis.  The chromatin was 
sonicated to yield an average fragment size of approximately 500 bp, pre-cleared with rabbit 
serum (anti-IgG, Millipore), and immunoprecipitated with an anti–acetyl H3K9 antibody 
(AcH3K9, Millipore) to recover acetylated histones and bound DNA.  The DNA was then 
purified, and enrichment at the Eng locus was measured by real-time PCR. Expression levels 
were normalized to Eng  -4 (Negative control region). List of primers used to quantify 
enrichment; Eng-8_F, 5’-TGTCATTGTCTTCTGGTCTC-3’; Eng-8_R, 5’-
ACACTCTCTGGGCATAGC-3’; Eng-4_F, 5’-AAGCGGCATTGGATATTG-3’; Eng-4_R, 
5’-AAGGTTAGGTTCGTTTGG-3’; EngP_F, 5’-ACTTCTCCTGACTTCTCC-3’; EngP_R, 
5’-CGGTATCCAGAGGTAAGG-3’; Eng+7_F, 5’-CCAGAGCAACTTGATGAC-3’; 
Eng+7_R, 5’-TACTCCTCCTCCTCCTTC-3’; Eng+9_F, 5’-TGGGTCAGGGTGAAATTCC 
-3’; Eng+9_R, 5’-AAGGCCGGTGATGTAGAGC-3’.  
 
Mouse embryo immunostaining and imaging 
10um thick cryosections of E10.5 fixed mouse embryos embedded in a gelation/sucrose 
solution were thawed and rehydrated in PBS prior to immunostaining.  The sections were 
streptavidin/biotin blocked followed by serum blocking (PBS with 10% FCS, 0.05% 
Tween20 and of 10% goat serum (DAKO) for 1 hour before the sections were incubated with 
primary antibodies at 4°C overnight in blocking buffer.  Immunostaining of E10.5 embryo 
sections was performed using purified rat anti mouse CD31 (553370, MEC13.3, BD 
Biosciences) (1/100) and guinea pig anti-mouse Lrp2 primary antibody (Dr Annette Hammes, 
Max-Delbrueck-Center for Molecular Medicine, Berlin).  Sections were washed three times 
in PBST for 15 minutes each and then incubated with fluorochrome-conjugated secondary 
antibodies Alexa Fluor(r) 488 Goat Anti-Rat IgG (A11006, Life Technologies) and Alexa 
Fluor(r) 647 goat anti-guinea pig IgG (A-21450, Life Technologies) at a 1/400 dilution.  
Sections were further washed three times in PBS and mounted using Prolong Gold antifade 
reagent with DAPI (Life Technologies).  Images were taken using a low-light time lapse 
microscope (Leica) using the Metamorph imaging software and processed using ImageJ. 
 
Generating zebrafish morpholinos and analysis 
Morpholinos against lrp2a (5′-AATCAGTGCTTGTGGTTTACCTGGG-3′,6), lrp2b (5′-
CACCACTCATGCACTGACCTGACCTGCACA-3′,7) and p53 (5′-
GCGCCATTGCTTTGCAAGAATTG -3′, 8) were purchased from Gene Tools. Lrp2a/b 
morpholinos were injected at increasing doses of 1ng, 2ng and 4ng each. The p53 morpholino 
was injected at a previously determined optimal dose of 4ng (Zon lab). The Lrp2 rescue was 
performed using a Human lrp2 vector obtained from Origene. Plasmid was linearized with 
Sfo1 and in-vitro transcribed using mMessage mMACHINE T7 kit (Thermo Fisher). The 
mRNA was injected at two different doses “low” (20pg/embryo) and “high” (100pg/embryo).  
Embryos were fixed at 36hpf followed by analysis of runx1 and cmyb expression in the 
AGM which was analyzed by in situ hybridization (as previously described9).  Zebrafish 
embryo images were taken with a Leica stereoscope. For the analysis of vascular integrity 
flk:zsgreen embryos were injected with the lowest effective MO dose of 2ng of each lrp2 
morpholino (lrp2a and lrp2b) as determined by in situ hybridization. Embryos were aged to 
32h. Ten embryos for each condition were anesthetized in 0.04 mg/ml Tricaine, mounted in 
1% low-melting agarose and imaged with a Leica stereoscope. A high-resolution image for a 
representative embryo of each group was acquired on a Zeiss confocal microscope.  
 
Analysis of adult peripheral blood and bone marrow 
Blood samples were diluted in PBS and analyzed using an Ac · T Diff analyzer (Beckman 
Coulter) using equine setting.  Suspensions of BM cells from the femurs were isolated and 
depleted of red blood cells by an ammonium chloride lysis step (STEMCELL Technologies, 
STEMCELL)). HSC and progenitor fractions were identified using the following antibodies: 
CD45-FITC or APC-Cy7 (Clone 30-F11 Biolegend), EPCR-PE (Clone RMEPCR1560, 
STEMCELL), CD150-Pacific Blue or PE-Cy7 (Clone TC15-12F12.2, Biolegend), CD48-
APC (Clone HM48-1, Biolegend), Sca-1-Pacific Blue or PE (Clone E13- 161.7, Biolegend), 
FLT3-PE or PE-Cy5 (Clone A2F10, eBioscience), CD34-FITC (Clone RAM34, BD 
Biosciences), c-kit APC-Cy7 (Clone 2B8, Biolegend), and a panel of lineage markers 
(Hematopoietic Progenitor Enrichment Cocktail, STEMCELL) plus streptavidinV500 (BD 
Biosciences). See 10 for details. 
 
Statistical analysis 
RT-PCR data, BL-CFCs and hematopoietic colony counts were statistically analysed using 
Student’s T-test or Paired Student’s T-test. Significant differences are marked * for p<0.05, 
** for p<0.01, *** for p<0.001 and not significant differences are marked NS.  
 
RNA sequencing and analysis 
Cells were sorted into IMDM/20%FCS and centrifuged. The cells were lysed in RNA lysis 
buffer/1% β-mercaptoethanol and snap frozen in liquid nitrogen. RNA was isolated from 
cells as per standard method (For details about samples refer to supplentary table S3), and 
amplified using the Ovation RNA amplification system V2 (Nugen).  Single-stranded TruSeq 
cDNA libraries were generated and sequenced using the Illumina HiSeq2000 analyzer (BGI, 
Hong Kong).  The sequencing reads were aligned to the mouse genome (GRCm38/mm10) 
using the software package TopHat.  Transcript expression for FLK1+/LacZ- and 
FLK1+/LacZ+ samples sorted from day 3 EBs was quantified with the software suite 
HOMER using standard parameters and two characteristically different bioinformatics tools, 
GFOLD and DeSeq, were used to identify differentially expressed genes.  GFOLD was used 
to identify genes with large fold changes (e.g. within the 1% and 99% percentiles of GFOLD 
estimates), and DeSeq was used to identify genes that significantly changed across sample 
populations (≤0.05). Samples were collected in triplicates, and each experiment was analysed 
independently to generate a list of DEGs. Heat maps were generated using the R package 
pheatmap [pheatmap: Pretty Heatmaps. R package version 061]. Patterns were generated 
based on normalized FPKM, with expression levels lower than 1/3 assigned as low (L), 
between 1/3 and 2/3 as intermediate (I), and more than 2/3 as high (H). Gene lists from each 
resulting category were analysed using Panther gene ontology program.  The data has been 
deposited in GEO under the accession number GSE77390. 
 
Pathway and Gene-set enrichment analysis 
The Ingenuity IPA Core Analysis Tool (version 17199142) was used to establish ‘Molecular 
and Cellular Functions’ that correlate with the lists of differentially expressed genes. Gene-
set enrichment analysis was performed using the GSEA Java Desktop tool (v 2.0.13). Gene-
expression levels were obtained from RNA-seq, and ranked using the GFOLD algorithm. The 
GSEA pre-ranked tool was used to interrogate the enrichment of various biological pathways 
provided by publically available databases such as Kegg and Biocarta. Other datasets were 
obtained from the GEO NCBI website; Ldb1 WT vs. Ldb1-/- (Accession number: 
GSE43044), Etv2+/- vs. Etv2-/- (Accession number: GSE31743), EC vs. HEC, and HEC vs. 
HSC (Data from 11 provided by Professor Elaine Dzierzak).  
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SUPPLEMENTAL FIGURE LEGENDS 
Figure S1 Characteristics and functional behaviour of Endoglin regulatory elements. 
(A) Table listing combinations of Eng regulatory elements tested in mouse transgenic 
reporter assays {Pimanda, 2008 #621}. Tissues with hematopoietic and endothelial activity; 
placenta, yolk sac (YS), dorsal aorta (DA), fetal liver (FL) and heart tissue were investigated 
for lacZ reporter gene expression in endothelial (E) and hematopoietic (H) cells. (B) Table 
listing the mouse/human coordinates and size of the Eng -8, P, +7, +9, +7Δ, +9Δ regulatory 
elements {Pimanda, 2008 #621}. (C) Table listing the combinations of the Eng enhancer-
driven LacZ reporter gene constructs which were used in this study.  
 
Figure S2. Generating recombinant mouse ES cell lines using combinations of the 
LacZ/Eng regulatory elements. (A) Schematic representation of the Hprt targeting strategy. 
Reporter constructs were cloned into the pMP8 plasmid between the 5’-3’ Hprt homology 
arms. After electroporation into HM1 ES cells, the respective 5’-3’ sites recombined and 
integrated the construct into the genome. The Eng -8/P/LacZ construct was used as an 
example in this figure. (B) Schematic of the recombinant Hprt locus. Successful 
recombination was verified by PCR and sourthern blots. (C) PCR#1 verified the integration 
of the targeting construct into the genome. Size of the PCR product varied from 1-2Kb 
depending on the type of insert. (i) Size of the PCR product for Eng-8/P ES cells was 1Kb. 
(ii) Size of PCR product for Eng-8/P/LacZ/+7 or +9 was 1.5Kb. (iii) Size of PCR product for 
Eng-8/P/LacZ/+7/+9 was 2Kb. (iv) Size of PCR product for Eng-8/P/LacZ/+7∆/+9 and Eng-
8/P/LacZ/+7∆/+9∆ was 2Kb. The positive control for each PCR was a pMP8 plasmid 
containing the corresponding construct. (D) PCR#2 verified the integration of the construct 
specifically into the Hprt locus. The PCR spanned from exon 2 in the targeting construct, to 
exon 3 in the endogenous Hprt locus. A 3.2Kb PCR product was detected for all successfully 
recombinant clones. No PCR product was detected for HM1 ES cells which lack exons 1 and 
2. (E) The southern blot analysis quantified copy number integration. The probe was a 250bp 
fragment that binds to a region between exons 3 and 4 of the Hprt locus. We detected a 6.5Kb 
band for the successfully recombinant clones, and a 9Kb band for HM1 ES cells. The white 
boxes highlight the southern blot band for each recombinant ES cell line tested.  
 
Figure S3. Bar charts showing BL-CFC numbers/3000 seeded cells sorted from day 3 EBs 
generated from recombinant ES cells. Experiments were performed in triplicate and repeated 
two times. Statistical analysis using students t-test, *P<0.05; **P<0.01; ***P<0.001; NS, not 
significant. 
 
Figure S4. RNA-sequencing comparative analysis of FLK1+/LacZ- and FLK1+/LacZ+ 
sorted fractions. (A) List of up- and down-regulated receptors and transcription factors in 
the FLK1+/LacZ+ cell population. (B) Gene network diagram showing genes upregulated in 
the FLK1+/LacZ+ fraction that are associated with the angiogenic and vasculogenic 
development network.  (C) Bar chart showing a list canonical pathways with highest p-values 
associated with genes up-regulated in the FLK1+/LacZ+ fraction. (D) Bar chart showing 
diseases and biological functions with highest p-value associated with genes up-regulated in 
the FLK1+/LacZ+ fraction. (E) Bar chart showing a list canonical pathways with highest p-
values associated with genes down-regulated in the FLK1+/LacZ+ fraction. (F) Bar chart 
showing diseases and biological functions with highest p-value associated with genes down-
regulated in the FLK1+/LacZ+ fraction.  
 
 
Figure S5. -8/P/LacZ/+7Δ/+9, and -8/P/LacZ/+7Δ/+9Δ mutant constructs do not enrich 
cells with hemogenic potential in HEI. At day 2 of liquid blast cultures, HEI LacZ+/LacZ- 
fractions were sorted and re-seeded in liquid blast media for 2 days and then seeded into 
CFU-C assays. (A) Bar chart showing the number of hematopoietic colonies generated from 
Eng -8/P/LacZ/+7Δ/+9 ES cells. (B) Bar chart showing the number of hematopoietic colonies 
generated from Eng -8/P/LacZ/+7Δ/+9Δ ES cells. 3x104 cells were seeded in methylcellulose 
mix. Primitive and definitive colonies were counted after four and nine days respectively. 
Experiments were performed in triplicate and repeated two times. Statistical analysis using 
students t-test, *P<0.05; **P<0.01; ***P<0.001; NS, not significant. 
 
Figure S6. RNA-sequencing analysis of ENG+/LacZ-, ENG+/LacZ+ and ENG-/LacZ+ 
HEI fractions sorted from day 2 liquid blast cultures. (A) GSEA plots showing the 
overlap of genes that are differentially expressed between ENG+/LacZ- and ENG-/LacZ+ 
HEI and genes in the hypoxia via HIF1a pathway (upper panel) and cell cycle regulators 
(lower panel). (B) Network diagram of genes that are associated with hematopoietic 
development and function and are upregulated in ENG-/LacZ+ HEI cells. (C-E) 
Differentially expressed genes within each cell fraction were further analysed based on their 
relative expression pattern across the three HEI populations. The FPKM values for each gene 
were normalized across the three populations, which resulted in a specific expression pattern. 
H=High, I=Intermediate, L=Low. The genes within each fraction were further analysed in 
PANTHER for their association with GO biological functions. (C) Analysis of genes 
differentially expressed in the ENG+/LacZ- HEI fraction. (i) Histograms displaying the 
expression pattern of genes in the HLL, HIL, HHL, and HHI. (ii) Table listing the biological 
functions associated with genes in each group. (D) Analysis of genes differentially expressed 
in the ENG+/LacZ+ fraction. (i) Histograms displaying the expression pattern of genes in the 
HHL, HHI, and IHL. (ii) Table listing the biological functions associated with genes in each 
group. (E) Analysis of genes differentially expressed in the ENG-/LacZ+ fraction. (i) 
Histograms displaying the expression pattern of genes in the LLH, IIH, LIH, and ILH. (ii) 
Table listing the biological functions associated with genes in each group. 
 
Figure S7. Functional and regulatory aspects of genes shared between FLK1+/LacZ+ 
cells from day 3 EBs and ENG-/LacZ+ HEI cells. (A) (i) List of common genes 
categorized into genes upregulated in both cell fractions (green), genes downregulated in the 
FLK1+/LacZ+ cells and upregulated in the ENG-/LacZ+ HEI (red), genes upregulated in the 
FLK1+/LacZ+ cells and downregulated in the ENG-/LacZ+ HEI (yellow). (ii) Gene 
regulatory network association between all three gene sets. (iii) The genes listed in table S6A 
were further analysed based on their relative expression pattern across the FLK1+/LacZ-, 
FLK1+/LacZ+, ENG+/LacZ- HEI, ENG+/LacZ+ HEI, and ENG-/LacZ+ HEI populations. (i) 
The FPKM values for each gene were normalised across all populations, which resulted in a 
specific expression pattern. H=High, I=Intermediate, L=Low (ii) Each gene set was analysed 
using genes2Canvas for their association with specific cell types. The canvas associated with 
each gene set was overlaid. (B) Bar chart showing the molecular and cellular functions 
associated with each gene set. (C) Table listing genes that were up-regulated in FLK1 
mesodermal (FLK1+/lacZ) and HE1 cells (ENG-/lacZ) that were targeted by Eng regulatory 
elements with a detailed description of their known functions and relation to hematopoietic 
development if known.   
 
Figure S8. Genes down-regulated in both FLK1+/LacZ+ cells from day 3 EBs and ENG-
/LacZ+ HEI cells. (A) Venn diagram showing the overlap and identity of genes that were 
down-regulated in FLK1 mesodermal (FLK1+/lacZ) and HE1 cells (ENG-/lacZ) cells. (B) 
Table listing genes from (A) with a detailed description of their known functions and relation 
to hematopoietic development if known. 
 
Figure S9. Lrp2 a/b and tp53 morpholinos. (A) Analysis of WT and lrp2a/b MO zebrafish 
for the presence of HSCs at 36 hpf following MO injections at 24 hpf. Low (left panel) and 
high (right panel) magnifications are shown and numbers in the panels indicate the number of 
embryos with the depicted phenotype. ISH for the HSC marker runx1. (B) ISH for cmyb 
following in lrp2a/b morphants co-injected with tp53MO to exclude non-specific cell death. 
 
Figure S10. LRP2 null FVB/N adult mice (A) Peripheral blood counts (Mean (SD)) from 9 
month old LRP2KO mice and littermates. (B) Bone marrow flowcytometry based assessment 
of MNC fractions. Differences were not significant. 
Endoglin transgenic construct Placenta YS DA Liver Heart Reference 
-8/P/LacZ No E  E  E medium H E Pimanda et al Blood 2006 Jun 15;107(12) 
-8/P/LacZ/+7 No E E E High H E Pimanda et al Blood. 2008 Dec 1;112(12) 
-8/P/LacZ/+9 No E E E medium H E Pimanda et al Blood. 2008 Dec 1;112(12) 
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Eng +9Δ Δ Gata sites 453 Pimanda et al 




Δ Ets sites 374 Pimanda et al 
Blood. 2008 Dec 
1;112(12) 
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LacZ -8 P +7 
LacZ -8 P +9 
LacZ -8 P +7 +9 
LacZ -8 P +9 +7Δ 
LacZ -8 P +7Δ +9Δ 
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PCR to verify integration of construct into the Hprt locus (PCR#2) 
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Canonical pathways associated with genes up-regulated in the 








Diseases and bio-functions associated with genes up-regulated in 
the FLK1+/LacZ+ cell population 
D 
Gene network governing angiogenic and vasculogenic 
development and function 
Down regulated cell surface 
receptors LogFC 
Down regulated transcription 
factors LogFC 
Cxcr2 -3.137 Churc1 -3.228 
H2-T23 -3.035 Znhit3 -1.523 
Lepr -2.193 Pfdn5 -1.435 
Ppp1r16b -2.167 Lhx1 -0.961 




Disp2 5.774 Utf1 4.471 
Cldn5 5.657 Mecom 3.468 
Tlr4 4.681 Ldb2 3.166 
Ptchd1 4.602 Gfi1b 2.611 
Cdh5 3.583 Hoxb5 2.543 
Tie1 3.352 Lyl1 2.382 
Ednrb 3.351 Sox7 2.182 
Esam 3.165 Erg 2.127 
Cd93 2.813 Bcl6b 2.082 
Pecam1 2.753 Cbfa2t3 1.968 
Cd34 2.725 Fli1 1.891 
Icam2 2.471 Sox18 1.837 
Tek 2.420 Ptrf 1.690 











































































































































































E Canonical pathways associated with genes down-regulated in the 


















































































































































































































































Diseases and bio-functions associated with genes down-regulated 


























































































































































































































































B Gene network governing hematopoietic development 
and function 
HLL HIL HHL HHI 
HHI HHL IHL 



















































positive regulation of immune system process 11.7 
myeloid cell differentiation 9.9 
immune system development 9.8 
hematopoietic or lymphoid organ development 9.8 
IIH 
leukocyte differentiation 7.4 
organ development 7.03 
cellular macromolecule localization 6.9 
LIH establishment of localization 5.4 
single-organism transport 5.4 
ILH 
regulation of protein phosphorylation 5.3 
regulation of cell migration 5.3 
regulation of cell motility 4.9 
Gene 




tube morphogenesis 10.7 
epithelial tube morphogenesis 9.9 
regulation of angiogenesis 9.5 
regulation of vasculature development 9.5 
HHI 
regulation of Ras protein signal transduction 9.1 
negative regulation of catabolic process 8.9 
muscle organ morphogenesis 8.4 
regulation of small GTPase mediated signal transduction 8.3 
HIL 
macromolecule metabolic process 6.9 
positive regulation of biosynthetic process 6.4 
positive regulation of cellular biosynthetic process 6.4 
regulation of actin filament-based process 5.8 
Gene 




positive regulation of developmental process 5.7 
regulation of developmental process 5.7 
regulation of cell differentiation 4.9 
regulation of localization 4.8 
negative regulation of cell differentiation 4.8 
negative regulation of developmental process 4.8 
HHI-
IHL 
developmental process 5.3 
system development 5.0 
protein metabolic process 4.9 
cellular process 4.8 
regulation of molecular function 4.5 










































































Common genes between D3 EB and D2 HE 
  
Genes Up in D3 EB 
and D2 HE 
Genes Up in D3 EB 
and down in D2 HE 
Gfi1b Adam15 Mecom 
Laptm5 Bcl6b Myct1 
Lrp2 Cd34 Nos3 
Lyl1 Cd93 Nr5a2 
Mpo Cdh5 Oasl2 











Genes Down in D3 
EB and up inD2 HE Eltd1 Ramp2 
1810032O08Rik Fmo1 Rasip1 
Chchd1 Fxyd5 Sh3tc1 
Hspe1 Gap43 Sox18 
Lsm3 Gimap4 Tek 
Phlda2 Gja4 Thbd 
Rpph1 Gpm6a Tie1 
Sec61g Icam2 Tlr4 
Ska1 Jag2 Tmem204 
Snrpg Klf2 Trim47 
Taf1d Lonrf3 Tspan18 






















































































































































































































































































































































































































































































































































































UP in D3 EB and UP D2 HE 
Gene Entrez Gene Name Disease or function Associated with hematopoiesis 
Gfi1b growth factor independent 1B transcription repressor 
Development of blood, bone marrow, cardiovascular system, 
connective tissue, embryonic stem cells, hematopoiesis in 
embryo,  hematopoietic progenitor cells, hematopoietic system 
and tissue, differentiation and maturation of blood and BM. 
Yes 
Laptm5 lysosomal protein transmembrane 5 Activation and prolifiration of blood cells (leukocytes, lymphocytes, T lymphocytes), delayed hypersensitive reaction. Yes 
Lrp2 low density lipoprotein receptor-related protein 2 
Abnormal morphology of embryonic tissue, brain, CNS, 
embryonic body, telencephalic vesicles, loss of neurons, 
cancer,conventional melanoma 
No 
Lyl1 lymphoblastic leukemia associated hematopoiesis regulator 1 
angiogenesis, apoptosis of blood and hematopoietic progenitor 
cells,development of blood cells, differentiation and function of 
hematopoietic progenitor cells, hematopoiesis of bone marrow, T 
cell development, thrombocytopenia 
Yes 
Mpo myeloperoxidase Abnormal metabolism, function of cardiovascular system, function and movement of blood cells, inflamatory response,  Yes 





DOWN in D3 EB and DOWN in D2 HE 
 
Gene Entrez Gene Name Disease or function Association with hematopoiesis 
Pdlim3 PDZ and LIM domain protein 3 
Transcription factor (non-motor actin 
binding protein) No 
Tmem86a Lysoplasmalogenase-like protein TMEM86 A   
Expressed in hematopoietic stem cells of the lateral plate 
mesoderm and cardiovascular system 
Cflar CASP8 and FADD-like apoptosis regulator Cysteine protease 
Widely expressed. Higher expression in skeletal muscle, 
pancreas, heart, kidney, placenta, and peripheral blood 
leukocytes 
Tor4a Torsin-4a Chaperone No 
Frem1 FRAS1-related extracellular matrix protein 1 cation transporter No 
Dennd5b DENN domain-containing protein 5B 
Ion channel, G-protein modulator, 
membrane-bound signaling molecule Expressed in mature B cells 




  Hb   WCC    PLT 
LRP2 KO 13.9 (1.69) 7.4  (2.12)  1098.5 (49.39) 
 





Genes Up-regulated in the FLK1+/LacZ- fraction













































































































Genes Down-regulated in the FLK1+/LacZ- fraction







































































































Genes Up-regulated in the ENG-/LacZ+ HEI population





































































































































































































































































































































































































































































































































































































































































































































Genes Down-regulated in the ENG-/LacZ+ HEI population
Gene Symbol logFC FDR
Crybb3 6.25650192 0.000354722
Cxcl17 6.15729044 0.006121384
Ly6g6e 6.14113513 0.015207308
Clcf1 6.12886931 0.000344337
Ccdc87 6.01920364 0.002263224
Kcnma1 5.81748514 0.00052578
Gja5 5.73413275 4.32555E-09
Slc41a2 5.54592025 6.60249E-06
Pcdhb14 5.41579617 0.005325232
Cftr 5.33818775 0.006788754
Hc 5.20317026 0.02040009
Fbxo40 5.13542033 0.014225415
Adamtsl5 5.10235581 0.01616849
Nlrp1b 5.04492195 0.015260874
Il7 4.93619933 7.33334E-05
Bmx 4.91850392 0.000121367
B230119M05Rik 4.85139145 0.019634188
Tbx3os2 4.78746119 0.046854014
Yipf7 4.78451146 0.015219914
Gbp11 4.78136599 0.020574987
Ido1 4.76348461 0.041332448
Eva1a 4.76262161 0.000251395
D930020B18Rik 4.75115005 0.03177312
E230025N22Rik 4.74596006 0.023740855
Tmem82 4.73257398 0.048941292
Fam19a3 4.69408279 0.000136769
Snph 4.57833549 0.041747333
Fam19a2 4.51858612 0.04735918
Trpm3 4.50268817 0.032075036
C1qtnf2 4.39069707 0.009430587
Clvs1 4.38407592 0.005507327
Gpihbp1 4.36945782 0.005771646
Pcdh9 4.35360008 1.47967E-09
S1pr4 4.21985657 0.00743091
Ifit1 4.18072192 0.01150381
Ccbe1 4.09615522 0.006109254
Ablim3 4.02702263 0.00216256
C1qtnf1 3.97657648 5.84737E-06
Abcd2 3.70273365 0.000520706
Npvf 3.70199549 0.029404986
Trnp1 3.6755603 0.024192528
Dpp4 3.66117546 0.008422956
9030617O03Rik 3.63402294 0.010635018
Ifit3 3.63391696 0.04613748
Scn3a 3.62772869 0.000267407
Sct 3.62674208 0.022430669
Slc2a13 3.57917944 4.57639E-07
Pdlim3 3.57766279 2.16822E-44
Cyp1a1 3.57720408 0.001905685
S100a16 3.5477518 2.13634E-11
Ly6a 3.42207613 2.62151E-12
Wbscr17 3.39468348 0.000355265
Pgbd5 3.38836145 1.56978E-05
Il1r1 3.34347429 6.40325E-07
Nr5a2 3.29320254 0.005750421
Cabp1 3.2728878 0.001120493
Grik3 3.26096666 0.018407656
Grin2c 3.24189718 0.005374654
Tmem53 3.22142009 0.034324076
Ramp3 3.20739422 0.048766901
Fst 3.19328629 2.98063E-08
Frrs1l 3.12797418 0.000686358
Tmem150c 3.12351529 0.037114187
Art3 3.08782442 0.012536686
Disp2 3.08746265 0.000118107
Rgs17 3.0588474 7.52981E-05
Clec1a 3.05635354 6.05317E-14
Gbp6 3.03879822 0.022181358
Slc4a8 3.02118734 0.001524407
D430019H16Rik 3.01525558 0.000230621
Dusp26 2.9637332 0.01634546
Prnd 2.92446708 0.013206311
2700070H01Rik 2.88477997 0.032301302
Arhgap22 2.8796337 0.048204754
Pdlim4 2.85391918 0.00816996
Sorcs1 2.85196135 0.001475148
Col13a1 2.84329058 0.019212038
Adrb1 2.8354098 0.000456481
Add2 2.80979515 2.00059E-07
Bcl11b 2.80191944 0.012637806
Tifa 2.77963433 0.008198429
Lsamp 2.77214612 0.023419121
Robo4 2.76257106 9.41069E-17
Pth1r 2.76119957 0.001401918
Cyp2j9 2.75723043 0.032898869
Thrb 2.74835614 0.028183712
Mamld1 2.72417862 3.71113E-10
Gabrb2 2.68033058 2.17158E-05
Tmem51 2.67281111 0.019634188
Pcdh20 2.66722287 0.001611227
Bean1 2.65069942 0.012145624
Ceacam1 2.6373882 1.44202E-05
Sema3g 2.61765129 0.043021926
Gpr85 2.59638848 0.03182126
Pde1b 2.58961839 0.002762568
Sspn 2.58675237 0.015013314
Gdap1l1 2.58446104 0.042010661
Tmem255a 2.57903553 4.55639E-07
Sh3rf3 2.55311261 0.00123892
Pipox 2.55237606 0.0035214
Prokr2 2.54834849 0.000884339
B3galt1 2.50824272 0.00062887
Clec14a 2.495834 1.60049E-20
Slc12a8 2.48508379 0.028101691
Zmynd15 2.4581337 0.000147643
H2-Q4 2.41962659 0.012238072
Tmem154 2.41479517 0.006344249
Eng 2.40375217 1.18852E-20
Ahrr 2.40185551 0.024671776
Ccdc110 2.40159921 0.047583515
Il13ra1 2.39997595 0.000174021
Itga2 2.38701229 0.001931815
9630013A20Rik 2.37734364 0.033826138
Fam78b 2.36416915 0.001063811
Cadps 2.36025135 0.046676127
Mrgpre 2.35622134 0.003300233
Gimap6 2.35545309 0.000497308
Pi16 2.35324086 2.97701E-05
Hgf 2.34764215 0.039717815
Plekhg1 2.34189511 4.95345E-11
Cntn1 2.32195392 0.018974153
Cxcl16 2.31527239 2.17805E-06
Cnr2 2.30573281 0.003227649
Edn1 2.29334971 1.65091E-37
Emcn 2.2678929 1.20303E-09
Cldn5 2.26712542 0.01179793
Apba1 2.25723727 0.00481876
Rnft2 2.25079995 0.00099635
Mdfi 2.24735098 0.002126928
Madcam1 2.24125549 7.8355E-07
Patl2 2.23629909 0.00515282
Nod1 2.22755616 0.017552353
D030045P18Rik 2.22492453 0.024330801
Sqrdl 2.22463208 0.01064127
Rgs16 2.2179511 1.7526E-06
Ddx60 2.21568307 0.038891191
Prickle2 2.21311122 5.94511E-14
Ptpn3 2.1918109 0.005325232
Sgk3 2.17972228 1.70099E-10
Cybrd1 2.17942797 0.036779379
Nfil3 2.17816349 9.43137E-05
Adam11 2.17718593 0.005319159
Gcnt4 2.16602276 0.00761664
Serpina3h 2.16119221 0.039303536
Dmrt3 2.15965709 0.022820026
Sparcl1 2.15468423 0.000784538
Adhfe1 2.1482248 0.007585006
Six3os1 2.14355335 4.33993E-05
Nrxn3 2.14053022 0.00347995
Slc35f1 2.11849147 4.76936E-05
Arhgap26 2.11760508 0.016344227
Pcdh17 2.10986521 0.002889373
Sh3gl3 2.10505529 0.034707678
Astn1 2.10033507 0.021058067
Cav1 2.09925614 2.47467E-12
Tnfaip8l3 2.09249146 0.007404196
Tchh 2.08068758 0.02013666
Tm4sf1 2.07157777 0.021439509
Oasl2 2.0665172 0.0320633
Chrdl1 2.06647352 0.015290546
Tnfrsf23 2.05117221 0.003416577
Pcdhga6 2.04796979 0.017445656
Gpr116 2.04274007 2.62151E-12
Fam181b 2.03893273 0.004535041
AI661453 2.02767285 0.011431788
Col14a1 2.00867795 0.014440187
Stx1b 2.00249944 0.023957118
Parp14 2.00240406 0.000385376
Cdh13 1.98465913 0.031087599
Map3k8 1.9826497 0.024648589
Pcdhb17 1.97473016 0.048005393
Qpct 1.97061125 0.010734992
Sost 1.95634788 1.97168E-06
P2rx7 1.95587017 0.005716443
Stc1 1.95258907 0.000216839
Cyyr1 1.94995899 7.75173E-07
Ace 1.94926618 0.000154083
Zbtb7c 1.94059935 0.024431012
Serpina3i 1.93230914 0.026420093
Mmp15 1.93131858 2.63802E-05
Rassf4 1.9211141 0.041461583
Nr2f2 1.91962709 5.46909E-05
Foxp2 1.905238 0.001840115
Rtn1 1.89810313 0.001200266
Stab1 1.89248725 2.62151E-12
Pdzd2 1.88789589 1.49745E-13
Nos3 1.88237258 0.000100201
Bend7 1.8759542 0.001789848
Gpr182 1.87323757 0.013116394
Dmd 1.87144785 3.33051E-06
Cttnbp2 1.86703161 3.99574E-07
Lor 1.86532742 0.01963896
Rab3b 1.85978302 0.00047339
Rnd1 1.85755109 0.041040905
Plekha6 1.85140994 0.031042368
Pde10a 1.84042583 0.010050368
Psmb8 1.83743045 0.027786063
Lhfpl2 1.83134969 1.4092E-06
Kcna6 1.82511296 0.000713988
Gap43 1.82032402 5.1548E-21
4933412E12Rik 1.81999082 0.035906793
Reep2 1.81576473 0.000671371
Nrxn2 1.81220385 0.019511153
Efna1 1.80689469 0.000608615
Ptprt 1.79154996 3.67473E-06
Rgs7bp 1.78985215 0.001521679
Cd93 1.78781028 1.47462E-09
Sh3bp5 1.78110259 5.89188E-08
Slc1a2 1.77465572 2.90794E-07
Gata4 1.77361085 1.4264E-11
Zfp658 1.76190117 0.006038733
Frem1 1.76071677 0.005881318
Dach1 1.75932814 0.043196035
Prex2 1.75415238 2.71593E-11
Xaf1 1.7535399 0.014937183
Tmem86a 1.75231894 0.030928756
Aqp1 1.74957919 1.0118E-05
Whrn 1.74534522 0.037114597
6330419J24Rik 1.74351345 0.004789365
Lgr6 1.73169891 0.000136049
Jag2 1.72948941 0.001174005
Mmrn2 1.72862416 6.0269E-06
Gpm6a 1.72616942 5.13097E-09
Dock4 1.72485324 1.76263E-08
Tmem44 1.7247415 0.002530932
Tmem204 1.72410478 7.78332E-12
Filip1 1.71678234 9.92226E-05
Fes 1.7156733 0.001740874
Gpm6b 1.71382644 6.7478E-08
Tshz3 1.70197523 0.001896077
Mansc1 1.69808565 0.002520927
Pcdhga3 1.69647693 0.006793952
Eml1 1.68342858 2.31344E-11
Cd97 1.68075811 2.15219E-13
Skida1 1.67905073 0.049871418
Grin3a 1.67260577 1.27927E-05
Bace2 1.67258507 7.14205E-05
Rtn4rl1 1.67004782 0.035545165
Ptprm 1.67001425 5.32352E-16
Hpgd 1.66644196 0.046158644
Ocln 1.66423534 0.003780024
Ago4 1.66418307 0.033067184
Sox17 1.66352056 4.86361E-17
Bmf 1.65824119 7.16797E-07
Plcd1 1.65246216 0.005508605
Arhgef28 1.64188196 0.004154036
Ccdc120 1.63713556 0.003731318
Gnai1 1.63104051 2.78741E-12
Epas1 1.62674831 1.54656E-16
Nrep 1.6241192 1.60062E-20
Dhrs3 1.61872683 4.9319E-05
Fzd1 1.61781646 3.26112E-08
Adcy4 1.61753975 5.52292E-10
Slc40a1 1.60771557 7.62751E-05
Kctd12b 1.60298537 7.39103E-08
Mturn 1.59050795 0.016730548
Ndrg2 1.58502795 0.012945763
Klhl8 1.58422961 0.001909046
Tnnt2 1.57898015 0.005477122
Met 1.57897949 0.000141575
Gm20748 1.56772455 0.000484413
Naalad2 1.56349374 0.011969237
Eltd1 1.56326302 3.64109E-07
Cxx1a 1.56195873 0.009435987
Dgkk 1.55921393 1.7379E-05
1810011O10Rik 1.55803329 2.83423E-06
Npdc1 1.55318398 0.007309947
Slc16a2 1.54823787 1.38332E-13
Lrrn2 1.54572792 0.000118107
Id2 1.53972139 5.81204E-09
Pdk4 1.53886892 0.009747462
Sema3a 1.53813239 1.66242E-06
Lrrk2 1.53395858 1.67821E-10
Ppp1r16b 1.53365855 5.76626E-09
Trim47 1.52365175 0.007798689
6430548M08Rik 1.517959 0.003489248
2510009E07Rik 1.50602202 0.000267407
Dok4 1.50596452 0.000513324
Oit3 1.5047518 0.000127365
Itpr3 1.50208177 2.87372E-06
Ankrd6 1.50197519 0.023957118
St8sia4 1.49910183 0.020200454
Cyp39a1 1.49807854 0.044400618
Erbb2 1.49752692 6.00543E-11
LOC102636514 1.48547575 0.003300233
B630019K06Rik 1.48122346 0.041391858
Adcy2 1.48104462 0.029844293
Tm6sf1 1.47720907 1.47462E-09
Fxyd5 1.47565629 0.008119747
Rgs2 1.47522281 1.38332E-13
Ramp2 1.4730347 6.55888E-06
Ube2l6 1.46985536 0.01150381
Emb 1.46430329 6.98299E-07
Angptl2 1.45622852 0.00019519
Klhl4 1.45505394 0.000394479
Cish 1.45430575 0.014270424
Rab15 1.4529967 0.022289537
Hecw2 1.45168155 3.97907E-08
Gimap8 1.44923421 0.003171631
Akr1b8 1.4480994 0.000354722
Rgs3 1.44669161 2.79034E-07
N4bp3 1.44325245 0.001014064
Nedd9 1.44126253 0.000682966
Acer2 1.43991526 0.001950725
Kctd21 1.43725253 0.017552353
Parp8 1.43446184 1.16695E-07
Pcdh12 1.43441496 8.06968E-14
Chst11 1.43216905 0.000491398
F8 1.43126819 8.64663E-06
Cpt1a 1.43019018 9.66042E-05
Hoxa1 1.42944378 0.036779379
Ctsl 1.42932441 2.78741E-12
Limch1 1.42881176 3.30849E-06
Gimap4 1.42612128 4.80559E-07
Acvrl1 1.41594839 3.91822E-08
Ptchd1 1.41513888 4.9372E-07
Gabrb3 1.41110383 0.001412391
5730409E04Rik 1.41066928 0.025586714
Bmp6 1.40916486 1.00348E-09
Tgfbr2 1.39565726 2.07504E-06
Cubn 1.3950718 0.012238072
Notch4 1.39434678 4.55768E-05
Ube2ql1 1.39284044 0.047761325
Upp1 1.39204852 3.57082E-06
Lpar4 1.38897623 2.34423E-09
Dab2 1.38709916 0.001707355
Icam1 1.38513664 5.82923E-05
Icam2 1.38476952 0.000439071
Rasgrp3 1.38203471 2.62151E-12
Mcam 1.38184493 6.96898E-06
Ehd2 1.38165765 1.28373E-07
Gprc5a 1.3813017 0.007857311
Prkch 1.38094944 0.004465313
Scrn1 1.37909994 0.025410734
Ctsh 1.37331548 0.000942925
Nav3 1.37169696 0.02505003
Atl1 1.37126786 1.29486E-06
Slc8b1 1.37035742 0.005082306
Spred3 1.36909934 0.01482001
Antxr2 1.36625734 0.004418737
Grrp1 1.3648216 0.000603886
Sema6d 1.36347571 5.29662E-08
Rgmb 1.36015967 0.004766197
Parvb 1.3598599 0.000213304
Sema3f 1.35666009 0.002533692
Lonrf3 1.3528561 7.2611E-06
Tlr4 1.34398922 2.0982E-05
Capn5 1.34397931 0.000152011
Cttnbp2nl 1.34265528 1.08006E-19
Adam12 1.34233974 0.000623682
Itpkb 1.33568824 2.03771E-05
Bgn 1.33373234 1.31763E-07
Pld1 1.33141477 7.46474E-07
Cyp4v3 1.32340215 0.010515006
Plagl1 1.32121121 0.000761453
Arid5b 1.31915449 2.34423E-09
Sgsh 1.31853498 3.23703E-05
Rcan3 1.31116263 0.000190286
Kctd17 1.31029115 5.46315E-06
Pdk1 1.30864086 0.000946184
Helz2 1.30753826 0.011276152
Atf3 1.30473364 4.0506E-08
Itga1 1.30115946 9.11806E-09
Fmo1 1.29472153 1.14916E-16
Adam23 1.29284152 1.69365E-06
Sox6 1.29150052 1.00407E-07
Prom1 1.2904929 0.015321403
Ppm1j 1.28898246 0.047736329
Slit2 1.28258055 0.00032164
Plvap 1.27866926 0.000509457
Fmo5 1.27415737 0.021229611
Tmem159 1.2686847 2.48102E-05
Gbp9 1.26835918 0.027665722
Psen2 1.26813081 0.019284155
Tmem173 1.26774222 0.013769531
Plcb1 1.26498936 3.06527E-05
Chrnb1 1.26357764 0.024844203
Ehd3 1.25677014 0.01482001
Cd40 1.25564798 1.04773E-05
Kdm7a 1.25316491 6.67987E-08
Hmcn1 1.24948206 4.9372E-07
Pcdh1 1.24821296 1.22328E-06
Timp1 1.24713649 0.043937948
Ppap2a 1.24317985 0.002303112
Dock8 1.23892721 0.000148873
Tfec 1.23820736 4.36716E-07
Dusp22 1.23817215 3.64109E-07
Rps6ka2 1.23780729 2.57761E-06
Mical2 1.23514769 0.000331948
Osbpl6 1.23223577 0.03023915
Rab3il1 1.23010403 0.008988872
Efnb2 1.22584467 2.74734E-12
Sat1 1.22396658 1.49832E-10
Sgk1 1.21928875 2.69762E-08
Fgd6 1.21646329 6.18775E-05
Rarg 1.21113647 0.012145624
Entpd1 1.20279758 0.035626622
Dnajb5 1.20061997 0.004435643
Ntn3 1.19496915 4.14625E-05
Rnf144a 1.19357888 4.43976E-05
Arsa 1.19298159 0.002530932
Arhgef15 1.18893214 7.14205E-05
Eps8 1.18844868 0.000134139
Tnks1bp1 1.18720037 0.001125329
Cerk 1.18674938 0.005050143
Gbp4 1.18608431 0.01858609
Ly96 1.18476099 0.045726424
Dennd5b 1.184206 7.51897E-07
Fbxl7 1.18064294 0.000529909
Elovl4 1.17998447 0.000442539
Tgfbi 1.17819143 0.030828711
D1Ertd622e 1.1708281 0.01179793
Gatm 1.16890665 0.002303112
Rgl1 1.16709318 1.04659E-11
Tie1 1.16496502 0.012145624
Ctgf 1.16010458 0.002370819
Cbx6 1.15982767 0.025410734
Epn2 1.15805733 3.92099E-12
Rnf165 1.15781922 0.00341342
Prdm1 1.15756418 0.019634188
Dysf 1.15635916 0.001690251
Usp27x 1.15446047 0.020712294
Itsn1 1.15339098 2.74734E-12
Cdh5 1.14956573 0.007024169
Mecom 1.1474593 0.00046904
Dtx3l 1.14619799 0.004151397
Ghr 1.14443005 1.16037E-10
Mfap3l 1.14063473 0.001320575
Rhpn2 1.13471415 8.84809E-05
Slc9a3r2 1.13254832 8.27541E-06
Filip1l 1.1321366 2.35311E-05
Tnfaip1 1.12721741 4.35839E-07
Sema6b 1.12467937 0.043443023
Rhou 1.1222825 8.03697E-08
Snrk 1.12179423 0.000265586
Plekha1 1.11979284 5.76626E-09
Stap2 1.11946019 0.000776078
Arhgef3 1.11938832 0.001529963
Fat4 1.11909352 3.34289E-07
AW551984 1.11908907 0.007970266
Ccdc80 1.11603822 2.42344E-05
Tmc8 1.11280255 0.031340642
Ccnjl 1.11244286 9.29763E-06
Ypel2 1.11039245 0.001306038
Abhd6 1.10911504 0.006734222
Sash1 1.10646508 1.34103E-08
Ampd3 1.10612842 0.000568351
Endod1 1.10538157 0.001393788
Sox18 1.10425759 0.025088085
Pced1b 1.1009767 0.004942393
Parp9 1.10007273 0.022590568
Parp10 1.09553229 0.046324916
C1qtnf6 1.0943025 0.003161654
40422 1.0923483 1.85027E-06
Zfp382 1.0912224 0.0406944
S1pr1 1.08836574 5.18886E-09
Acsf2 1.08560817 0.003227649
Mdfic 1.08416514 0.001233198
Trim16 1.07769101 0.001032334
Ptprd 1.07514088 8.71795E-07
Heg1 1.07463882 0.00010943
Glul 1.07355443 7.25498E-11
Flrt2 1.07101031 1.05183E-09
Armcx1 1.06964681 1.16037E-10
Nipal3 1.06883569 0.044565478
Sft2d2 1.06801998 3.96543E-07
Gpr126 1.06463852 0.047141713
Fbn1 1.06250049 4.67821E-06
Fstl1 1.05755394 4.3809E-09
Zfp618 1.05376379 0.028880357
Cers6 1.05354182 0.010272676
Prickle3 1.05255551 0.012461136
Klf4 1.05032488 3.34249E-07
Arhgap31 1.04630502 3.25179E-05
Ap1s2 1.0448927 9.42993E-07
Gja4 1.04113201 0.043941057
Hand2 1.03844154 2.03771E-05
Asb4 1.02904765 0.026253214
Mxi1 1.02840984 0.000569955
Slc17a5 1.02556749 0.009523916
Bcl2 1.02445677 0.00882067
Tlr3 1.02388561 7.66505E-05
Rhob 1.02378506 0.000358687
Meis2 1.02254553 0.019922414
Gpr146 1.02105459 0.011179574
Fam114a1 1.02104151 6.58615E-08
Cd109 1.02066387 0.015844706
Vash1 1.01960591 0.000539094
Lmf1 1.01835716 0.047145219
Peli2 1.017516 0.001315988
Maf 1.01633322 0.044860977
Mroh1 1.01533484 0.00173172
Plat 1.01210985 0.025681478
Trim2 1.00916577 0.028999329
Tcf4 1.00896003 1.76263E-08
Rcsd1 1.00162662 0.014440187
Thbd 1.00146299 0.03023915
Slc26a10 1.00080202 0.002174643
Elk3 1.00021479 1.28227E-05
Cpne8 0.99605113 0.024692245
Rusc1 0.99581914 0.039975742
Peg10 0.99468146 1.01047E-05
Lipa 0.99340069 1.24628E-07
Pdgfb 0.99193709 0.001178785
Tmem2 0.99150421 3.05746E-06
Prrg3 0.99149258 0.000596048
Atg10 0.99136987 0.019634188
Kank1 0.98701352 0.007340664
Myct1 0.98380908 0.023446821
Fblim1 0.98165366 0.000130731
Pitpnc1 0.98138227 0.001690251
Camk2d 0.98066506 2.17158E-05
Spats2l 0.97784568 0.000264676
Plp2 0.97773516 1.0606E-09
Phyh 0.97773444 0.027919545
Pik3r3 0.97521746 3.45092E-06
Anxa5 0.97421157 4.41668E-10
St3gal6 0.97298244 0.001053936
Bcl6b 0.97270841 0.00912701
Arap2 0.97066286 0.000237722
Plod1 0.97031481 1.95941E-07
H2-D1 0.97008472 0.018813997
Ushbp1 0.96956833 0.003222281
Cd55 0.9675418 0.000195384
Id1 0.96676281 1.91118E-06
2900026A02Rik 0.96611254 6.67852E-06
Kif3c 0.962524 0.002407405
Smad6 0.96122668 0.001840092
Gnal 0.95992629 0.01006963
Marveld1 0.95928409 0.000491459
Asap2 0.95866243 1.61566E-07
Dusp1 0.95834233 1.95941E-07
Slc5a3 0.95613095 8.27149E-06
Vim 0.95304285 1.14278E-08
Slc16a13 0.95140597 0.021745481
Slc43a3 0.95098653 0.00252015
Bmper 0.94912401 0.025921359
App 0.94760363 0.000198842
Otud1 0.94066555 0.019591334
Wbscr27 0.93455272 0.025668121
Leprel2 0.93089559 0.025464706
Ece1 0.92701377 8.23016E-07
Acvr1 0.92537402 0.001690251
Zeb1 0.92283183 0.000413386
Prnp 0.92205661 0.006862971
Atp11a 0.91993892 9.81911E-08
Crybg3 0.91509299 0.000399004
Pqlc1 0.91466376 0.01323112
Plxnd1 0.91335683 3.94278E-06
Rasip1 0.91306805 0.031221634
Slc6a6 0.91284416 1.05547E-06
Asah2 0.91209642 0.000475057
Ndrg1 0.91198646 0.042754269
Mboat2 0.9107657 0.003756264
Hexb 0.91047392 0.018134441
Apbb2 0.90950282 0.000638892
Dcbld1 0.90927245 0.015219914
Myo6 0.90924173 0.002158363
Nfkbia 0.90666537 0.029404986
Edil3 0.90292285 0.02174393
Mcc 0.89900153 4.53883E-05
Znfx1 0.89539114 0.004942393
Armcx4 0.89529063 3.74857E-11
Ankrd44 0.89363822 0.011299418
Plk2 0.89271298 2.3896E-06
Jup 0.88980737 1.0674E-06
Prkce 0.88971728 0.000242988
Trib1 0.88855817 0.000164087
Sirpa 0.88847172 0.0032421
Sh3rf1 0.88714516 7.95249E-05
Herc3 0.88713647 0.02040009
9430020K01Rik 0.88711749 1.00867E-05
Nfib 0.88684759 0.006734222
Bcl2l11 0.88607971 3.79149E-07
Nagk 0.88524847 0.001014064
Peg3 0.88415645 0.001693132
Ttc28 0.88037653 0.00047339
Tbc1d9 0.87763921 0.005050143
Lcp1 0.87577972 0.017552353
Fbxo10 0.87553724 0.000484413
Dhx57 0.87543092 9.81911E-08
Tor4a 0.87431145 0.014140212
Tanc1 0.87249721 1.15752E-07
Fgd5 0.87024341 5.29662E-08
Rras 0.87010233 3.52916E-05
Klhl13 0.86815254 1.01595E-05
Klf2 0.8669513 0.000232828
Fam69a 0.86321708 0.010592548
Wsb2 0.8629341 0.000353186
Rims2 0.86275048 0.015219914
Dusp6 0.86100696 7.86127E-05
4931406P16Rik 0.85821535 1.14463E-06
Gng11 0.85577535 0.00010029
Col4a1 0.85572026 1.27974E-08
Fyn 0.85458237 0.030073173
Vegfc 0.85317872 0.00912701
Mllt6 0.85243076 5.50239E-05
Tmem176b 0.85234919 0.00759766
Dgkh 0.85065338 0.005557702
Id3 0.84983369 8.69853E-07
Ltbp1 0.84714648 0.01858609
Klf6 0.84618231 0.007412582
Procr 0.84381173 0.021201829
Jag1 0.84337645 0.04692825
Zfp532 0.84197757 4.20211E-05
Tapbp 0.83940005 0.016952314
Col4a2 0.8384229 1.59634E-07
Dlc1 0.83789397 1.50457E-07
Creb3 0.83774535 0.008378562
Nid1 0.83665967 0.016884793
Pcdhgc3 0.83645238 0.003073471
Tspan18 0.83628395 0.032760213
Arhgef5 0.8333038 0.001135402
Tmc6 0.83177248 0.014936968
Cdr2l 0.83123085 0.000689689
Gpr137b 0.8308372 0.01399787
Amotl1 0.83002043 2.79154E-05
Arhgap27 0.82950263 0.001339082
Lpar6 0.82549977 0.002249377
Osbpl3 0.82535908 0.039860331
Ermp1 0.82500645 5.20026E-05
Unc13b 0.82464396 0.004253621
Cd38 0.8242372 0.005069433
Rin2 0.8241474 0.01146119
Lrrc8c 0.82394381 0.000134139
Palld 0.82388517 0.000702081
Ralgapa2 0.82382984 0.013376559
Rragd 0.82216875 0.009409538
Hyal2 0.82155336 0.001091906
Creb3l2 0.82147014 7.94869E-05
Zfp462 0.82053886 0.035502939
Btbd3 0.82036163 0.00057821
Nxpe3 0.81835438 0.007625924
Hspa12a 0.81816773 0.000497308
Spag9 0.81544543 6.30049E-05
Sh3tc1 0.81403036 0.001037751
Pam 0.81334126 3.52916E-05
Pim3 0.80868711 0.003911677
Pros1 0.80804587 0.000529909
Fam115a 0.80737277 0.000643508
Anxa3 0.80582012 0.00759766
Notch1 0.80494113 3.83317E-05
Crmp1 0.80486172 0.02670682
Rasal2 0.80465513 3.53388E-05
Sparc 0.80441467 0.000108353
Mef2a 0.80342491 0.003423088
Nhsl1 0.8027688 0.00046271
Camk4 0.8025306 0.005352197
Tek 0.80198983 0.025731459
5031439G07Rik 0.80153495 0.022986871
Tbc1d12 0.80113584 0.024554354
Dcxr 0.79980701 0.014862217
Kdr 0.79919545 0.000147643
Pde1c 0.79849955 0.035981062
Klf9 0.79835413 0.049000364
3110043O21Rik 0.79722091 0.045899837
Hsd17b11 0.7968532 0.008376881
Wwtr1 0.79563496 3.1261E-06
Mtch1 0.79150964 4.57888E-07
4930402H24Rik 0.78917036 0.003071407
Ankrd50 0.78902273 3.65637E-06
Ppp3ca 0.78851049 7.03897E-05
Pgap1 0.78722922 0.011690857
Man1a 0.78141342 0.000204243
Ezh1 0.7813293 0.000650618
Serpinf1 0.77974119 0.020078977
Fam43a 0.77910444 0.000544414
Lcorl 0.77650167 0.000106664
Cntln 0.77580148 0.034255696
Pvr 0.77573143 0.0007004
Pcyt1a 0.77081897 0.001756583
Rnf157 0.76917696 0.000185175
Srgap1 0.76881999 1.88927E-05
Unc5b 0.76821385 0.023645943
Gpr19 0.76784159 0.022322881
Adarb1 0.7638246 0.019634188
Crip2 0.76264077 0.000603523
Enox2 0.76209522 0.003227649
Tnc 0.76201871 0.012079092
Myo1b 0.75987452 0.001370017
Lama4 0.75747045 0.013495977
Palm 0.75488996 0.010068361
Mef2c 0.75433857 0.047869168
Obfc1 0.75209303 0.000770405
Gsto1 0.75191683 0.048700709
Adam15 0.75179566 0.000459628
Clip2 0.75089598 0.012250073
Rilpl1 0.75064451 0.023134393
B2m 0.75057654 0.000235722
Crip1 0.75031877 0.002889373
Mageh1 0.74814737 0.014737269
Prr5l 0.74490322 0.034017929
Atp2b4 0.7420747 0.046466866
Ets1 0.7412154 0.000303905
Hpcal1 0.73952115 0.012987777
Pecam1 0.73847653 0.037844023
Pbxip1 0.73775555 0.005000647
Camsap2 0.7373141 0.009287807
Elmo1 0.7370861 0.005507327
Pcnx 0.73615789 3.94535E-05
Tmem176a 0.73606916 0.036898442
Srr 0.73201569 0.02533065
Akap12 0.73179423 0.013115436
Vegfa 0.73158639 0.004535041
Uap1l1 0.73105184 0.002278496
Hykk 0.72645343 0.000945975
Ephb4 0.72564068 9.43137E-05
Man2a1 0.72442335 2.48102E-05
Rab11fip3 0.72286423 0.000264676
Dse 0.72239888 0.017934181
Klf3 0.7220224 0.000852713
Gria3 0.72143183 0.011027841
Renbp 0.7185534 0.002433371
Vwa5a 0.7183543 0.000185665
Arhgef12 0.71826823 2.64054E-07
Dscr3 0.71820235 0.013373111
Klf12 0.71801859 0.042038097
Mest 0.71748714 0.02435718
Add3 0.71507281 0.012250073
Tnip1 0.71391741 0.046323861
Foxp1 0.71179306 0.007440962
Agtpbp1 0.7110216 0.047479631
Atxn1 0.70765713 0.047746792
Ublcp1 0.70538133 0.001442801
Slc36a1 0.70482982 0.034707678
Ecscr 0.70482623 0.00114924
Nfkbiz 0.70403005 0.03182126
Ltbr 0.70389335 0.013710817
Ift122 0.70383341 0.0163981
Ptprb 0.70281707 0.012058309
Ehd4 0.70160983 0.001007446
Shroom2 0.70152849 0.002080608
Caskin2 0.70133712 0.000825178
Jun 0.69962255 0.001690251
Colec12 0.69953303 0.00064055
Usp29 0.69942113 0.021813981
Dcaf12l1 0.69936957 0.030760077
Thsd7a 0.69934142 0.006517304
Ralb 0.6988076 6.72988E-05
Rffl 0.69851775 0.028467784
Gcc1 0.69814953 0.036533027
Diap2 0.6974635 0.000107239
Hivep1 0.69726877 0.001151491
0610031J06Rik 0.69448255 0.001056958
Nrp1 0.69364745 0.000413386
Hdgfrp3 0.69162281 0.017150534
Pdlim1 0.69026258 0.00588207
Cmtm6 0.6882245 0.007776813
Tbc1d24 0.68781396 0.000761453
Grina 0.68632164 0.03875513
Ssfa2 0.68422394 0.000529909
Slc31a2 0.68153524 0.030759745
Crebrf 0.67763436 0.01150381
Rab31 0.67591862 5.17294E-05
Nfatc1 0.67566145 0.000358201
Ankrd46 0.6737142 0.014225415
Eogt 0.67287239 0.000279617
Tmem136 0.67127123 0.020783337
Tmtc2 0.67104799 0.02269917
Zfp423 0.66883462 0.000868266
Nhsl2 0.66800437 0.045635912
Phactr2 0.66526633 0.000168442
Aplp2 0.66374113 0.002158363
Plxnc1 0.66342244 0.046158644
Zfp37 0.66136321 0.046466866
Maged2 0.66117415 0.001690251
Gdpd1 0.6590052 0.012339667
Spats2 0.65873136 0.012461136
Abhd17a 0.65611991 0.042241708
Rnf19a 0.65543242 0.011892489
2810025M15Rik 0.65526736 0.03018424
Trerf1 0.6552643 0.032909333
Phldb1 0.65390566 0.033454148
Cmtm3 0.65378612 0.002099005
Map4k5 0.65273535 0.000682966
Rftn1 0.65088843 0.007188629
Mapre2 0.65072114 3.04588E-05
Car13 0.6501821 0.029781297
Rap2a 0.6495413 0.00012727
Sorbs1 0.64864152 0.005769709
Anxa6 0.64795673 0.005050143
Aldh3a2 0.64686485 0.007871539
Trp53inp2 0.64632375 0.006543975
Dock11 0.64291223 0.001077678
Fermt2 0.64276518 0.001317511
2010111I01Rik 0.64226543 0.023531808
Kdelc2 0.64148983 0.032128846
Rnf185 0.64126914 0.006954703
Cpped1 0.64121622 0.020014143
Acox1 0.64033263 0.003251755
P4ha1 0.64031227 0.023531808
Ucp2 0.63959579 0.013484556
Litaf 0.6387186 0.000584105
Klhl24 0.63412857 0.000617457
Ddx26b 0.63165374 0.000923543
Tbx3 0.6314738 0.01128909
Neo1 0.63074852 0.001151491
Dcaf6 0.62954061 0.02505003
Tmbim1 0.62939469 0.003961101
Sin3b 0.62730055 0.00687311
Ctns 0.62718535 0.024164708
1700017B05Rik 0.62710297 0.006939776
Stk39 0.62697845 0.029616385
Pabpc4l 0.62383771 0.039717815
Psap 0.62363956 0.002904454
Bcorl1 0.62358615 0.044217964
Rcan1 0.62350671 0.007890401
D8Ertd82e 0.62298176 0.020080206
Pald1 0.62157232 0.004155895
Hspg2 0.62080375 0.023583472
Mfsd1 0.62021811 0.014816049
Tram2 0.62013336 0.017156973
Timp3 0.62007929 0.045270638
Large 0.61708174 0.00070527
Mrps18a 0.61666294 0.01963896
Ap1b1 0.61648275 0.026554312
Atp7a 0.61478233 0.000656631
Cdk19 0.61444285 0.003519578
Ddah2 0.61139152 0.000539094
Pcmtd2 0.61134989 0.041391858
Wdr59 0.61015405 0.001261071
Txndc12 0.60745129 0.017302164
Sh2d3c 0.6070239 0.046485043
Ctsb 0.60682587 0.002415398
Coro2b 0.60484299 0.015178259
Sntb2 0.60408587 0.023485284
Dram2 0.60395019 0.003681232
Snx33 0.60357863 0.042833276
Ctsz 0.60319387 0.042038097
Dpysl3 0.60275999 0.023848921
Hbp1 0.60202876 0.001246888
Pygb 0.60159009 0.024938826
B4galt1 0.60021312 0.009472726
Chst2 0.59935197 0.044317282
Itm2a 0.59934598 0.016952314
Fam3c 0.59884264 0.002171325
Lrp5 0.59853274 0.004574116
Dst 0.59845677 0.04029844
Tjp1 0.59775217 0.002024504
Tulp4 0.59769468 0.042038097
Ankrd12 0.59745828 0.031663064
Magi3 0.59609837 0.000744992
Cds2 0.59605618 0.003453483
Agap1 0.5959778 0.000824873
Snx30 0.59496096 0.001178785
Tirap 0.59184831 0.04215328
Laptm4b 0.59147045 0.016153005
Nckap1 0.59012864 0.000861761
Trio 0.58716907 0.001049105
Ccser2 0.58667636 0.012536686
Ctsa 0.58558901 0.002521886
Zfp365 0.58450017 0.010050368
Mrps6 0.58421779 0.015953899
Dip2a 0.58319374 0.012216594
Msn 0.58263225 0.002146891
Fuca1 0.58182629 0.030945311
Myl12b 0.58058091 0.003073471
C1galt1 0.58014878 0.044217964
Arhgap32 0.58007553 0.019465196
Cd81 0.57997559 0.002473598
Bin1 0.57985951 0.022188608
Ppm1f 0.57934618 0.009875557
Slc35f5 0.57639734 0.011713162
Frmd4b 0.57613481 0.001740874
Nbea 0.57567119 0.013359638
Fam149a 0.57540988 0.031478578
Gas6 0.57495921 0.024093476
Ttc21b 0.57463453 0.047145219
Cflar 0.57426542 0.010484254
Tet2 0.57397044 0.021805972
Abca3 0.57208283 0.039347379
Cdc42bpb 0.57079366 0.002730013
Kank2 0.56893831 0.000687737
Pea15a 0.56454173 0.007986298
Tmeff1 0.56339126 0.002796434
Map4k3 0.56184021 0.007739628
Calcoco1 0.55926819 0.021813981
Lphn2 0.55915459 0.028792274
Frmd4a 0.55909661 0.009381743
She 0.55727128 0.014278091
Bex2 0.55682153 0.017018905
Fam222b 0.55582617 0.003171631
Tjp2 0.55518464 0.047736269
Gabarapl1 0.55411434 0.027968234
Bcl2l2 0.55379105 0.025731459
Macf1 0.55359979 0.008348814
Cyth3 0.55158306 0.017107797
Tcf7l2 0.54950471 0.019670119
Mapk3 0.54926569 0.012042675
Sypl 0.54779776 0.002164505
Casd1 0.54730099 0.004621678
Ndel1 0.54515163 0.032707262
Elovl5 0.54455376 0.007198543
Zfyve1 0.5429496 0.034501245
Gm16515 0.54253368 0.030750353
Oxct1 0.53889576 0.003227649
Hexa 0.53755868 0.010353402
Hip1 0.53669525 0.003779115
Akt3 0.5358331 0.002640916
Ctnnb1 0.53480571 0.002134974
Gna12 0.53476745 0.036457407
Tmem106b 0.53293082 0.00983404
Kctd10 0.53232996 0.005050143
Dlg5 0.53052194 0.026201187
Copg2 0.52907354 0.007441806
Klhl6 0.52885112 0.043764027
Bmpr2 0.52816564 0.012806133
Arhgef11 0.52804764 0.04460364
Tenc1 0.5270311 0.046485043
Exoc4 0.52598929 0.013850109
Grn 0.52512264 0.017073221
Sccpdh 0.52503297 0.020276582
Asah1 0.5240867 0.004107884
Adipor1 0.52219677 0.027909075
Cd34 0.52113702 0.044968769
Sptbn1 0.52107557 0.011841617
Dmwd 0.51969525 0.034731938
Steap2 0.51959855 0.016884793
Acbd5 0.5192529 0.010635018
Fam129b 0.51726306 0.045007815
Sri 0.51476517 0.027981567
Myo1c 0.51023212 0.026664828
Anapc2 0.5094904 0.047761325
Clip1 0.50854321 0.045970845
Usp32 0.50601689 0.006862971
Lrrc58 0.50208572 0.014354849
Lrrc8a 0.50131466 0.015484623
Numb 0.50039981 0.038467385
Tgoln1 0.49960455 0.020080206
Hdac7 0.4984747 0.021512228
Yipf3 0.49814051 0.04568778
Rab12 0.4976599 0.016680184
Lamp2 0.49504798 0.00331656
Cdh2 0.49261398 0.044437726
Slk 0.49239968 0.04613748
Cobll1 0.49228499 0.046238274
Sptan1 0.4915641 0.006608602
Ctsd 0.49134742 0.006278841
Slc44a2 0.49073396 0.014312804
Nav1 0.48608593 0.012488255
Pxdn 0.48546871 0.047497123
Dock6 0.48544075 0.026055774
Cnppd1 0.48498683 0.036442504
Srgap2 0.4838278 0.015024717
Mpzl1 0.48375674 0.004183166
Smad1 0.4829588 0.0470535
Il6st 0.47740513 0.016300121
Pik3c2a 0.47232209 0.020342359
Ppp1r9a 0.47205388 0.032031301
Fkbp9 0.47062321 0.031063557
Lgals8 0.47012918 0.037800364
Atp2b1 0.46992678 0.005771646
Npc1 0.46778791 0.030749983
Atp2c1 0.46589562 0.02782276
Yes1 0.46384103 0.032301302
Tspan9 0.4601918 0.019634188
Nrp2 0.45803467 0.031478578
Dusp16 0.45754214 0.046634435
Iqgap1 0.45699364 0.039120924
Map3k3 0.45523166 0.016592229
Qk 0.45351265 0.031272574
Dock1 0.4495832 0.047761325
Btg1 0.44955823 0.038726639
Actn4 0.44890813 0.010940718
Carhsp1 0.44872969 0.022590568
Adcy6 0.44322494 0.027909075
Ptk7 0.44099911 0.046270724
Itga5 0.43983133 0.019283968
Man2b1 0.43442997 0.020610191
Ugp2 0.4328997 0.035589807
Map3k11 0.43032825 0.034398076
Fam135a 0.42739733 0.04226346
Pdlim5 0.42663236 0.036732568
Triobp 0.41876773 0.02533065
Gng12 0.41696342 0.042038097
Ptpn14 0.41348236 0.039033139
Piezo1 0.40509281 0.036447588
Skil 0.39370361 0.04302612
Map4k4 0.39335155 0.043693615
Lamp1 0.37683457 0.044951032
Maged1 0.37170291 0.041391858
Trim33 -0.3573469 0.046505472
Gspt1 -0.3605518 0.049871418
Sqle -0.3611902 0.047497123
Tardbp -0.3666847 0.0450795
Tcerg1 -0.376228 0.04692825
Psmb6 -0.3846357 0.034358015
Hnrnph1 -0.3850724 0.041383915
Orc3 -0.386385 0.049501447
Sf3a1 -0.3926086 0.029792015
Med14 -0.3953839 0.035347688
Ola1 -0.396888 0.030828711
Stip1 -0.3980127 0.025731459
Rrm1 -0.40015 0.048973333
Set -0.4020976 0.019634188
Pdcd11 -0.4036084 0.036446307
Pkm -0.4037588 0.033126447
Ncapd2 -0.4068065 0.034632648
Xpo5 -0.4114309 0.043826737
Utp6 -0.4115701 0.031272574
Wdr75 -0.4123941 0.032767466
Tyms -0.4180273 0.030749983
Mybbp1a -0.4199431 0.027692569
Smarcc1 -0.4207404 0.010592548
U2af2 -0.4218187 0.036356386
Nup62 -0.4218858 0.03659348
Epb4.1l5 -0.4222133 0.034933449
Ddx18 -0.4238809 0.019037708
Cops5 -0.4239614 0.047519961
Znrf3 -0.4252158 0.039120924
Cirh1a -0.4273012 0.025731459
Plagl2 -0.4287221 0.037114187
Ttll4 -0.4302274 0.036453576
Rae1 -0.4322049 0.02672746
Fam210a -0.4326129 0.033370023
Larp7 -0.4335868 0.01353108
Hnrnpc -0.433706 0.04463755
Cpsf6 -0.4344144 0.031087599
Nsun2 -0.4344325 0.049403296
Nme1 -0.4416846 0.018530298
Aifm1 -0.4417268 0.039476839
Denr -0.4420595 0.048771943
Mre11a -0.4431858 0.039975742
Nup160 -0.445214 0.017009718
Nup155 -0.4457544 0.014937183
Psmb3 -0.4494857 0.024434239
Snrnp70 -0.4500929 0.034951497
Smn1 -0.4510802 0.047761545
Fasn -0.4512933 0.012637806
Plcl2 -0.4526148 0.0450795
Fastkd2 -0.4526201 0.043052075
Dtl -0.4527959 0.045979705
Gins2 -0.4540335 0.042494308
Ppat -0.4559212 0.01150381
Fus -0.4564607 0.0163981
Dhfr -0.4572799 0.036850504
Atic -0.457867 0.038996551
Acaca -0.458071 0.033011588
Mms22l -0.458251 0.043693714
Wdr3 -0.4585454 0.047622621
Utp11l -0.4591145 0.04692825
Hat1 -0.459847 0.039717815
Usp24 -0.4598783 0.013999324
Hells -0.4618291 0.019912997
Rsl1d1 -0.4630114 0.008975873
Tacc3 -0.4632733 0.023047439
C1qbp -0.4654797 0.019284155
Khsrp -0.4659537 0.025432283
Erh -0.4663217 0.012250073
Nudc -0.4675083 0.023153375
Eif4e -0.4700993 0.01482001
Ruvbl2 -0.4714274 0.017155849
Frs2 -0.4737451 0.020031543
Fgfr1op -0.4764688 0.02174393
Rsl24d1 -0.4794557 0.030886228
Gatad1 -0.4821751 0.004813209
Phb -0.4823853 0.026336996
Park7 -0.4844912 0.03428394
Tsr1 -0.4870355 0.025432283
Chaf1b -0.4875325 0.031945563
Myo19 -0.4878522 0.041255062
Trmt6 -0.4884361 0.034951497
Cct3 -0.4887553 0.005374654
Chek1 -0.4912268 0.033067184
Rcc2 -0.4921252 0.014225415
Cacybp -0.4933062 0.027808796
0610007P14Rik -0.4934913 0.032181752
Ticrr -0.4936432 0.015447187
Oat -0.494166 0.005101356
Ing5 -0.4949474 0.026264805
Psmg1 -0.4960053 0.018685955
Tuba1c -0.4960215 0.001909046
Cks1b -0.4983408 0.010068361
Dkc1 -0.500082 0.025502096
Mlec -0.5010375 0.003793243
Wdr18 -0.5016548 0.027602575
Eef1d -0.5016561 0.005029593
Gpn1 -0.50166 0.031272574
Kif20a -0.5021924 0.020251678
Gfpt2 -0.5025914 0.038891191
C330027C09Rik -0.503346 0.020767104
Rrp1b -0.5039365 0.004155895
Jade3 -0.5045377 0.04865351
Phlda1 -0.511139 0.015484623
Mrps30 -0.5112446 0.03023915
Nsdhl -0.5131118 0.004035043
Emg1 -0.514678 0.03023915
Pitrm1 -0.5148078 0.036723138
Dazap1 -0.5151004 0.043443023
Pcna -0.5155391 0.006109254
Eno1b -0.5159822 0.027909075
Pspc1 -0.5165724 0.026849481
Cenph -0.5175012 0.034731938
Srm -0.5186396 0.012896026
Uhrf1 -0.5191902 0.002298833
Nol10 -0.5216314 0.036225763
Eif5a -0.5225901 0.000901976
Rfc5 -0.5234656 0.040120088
Seh1l -0.523609 0.001159918
Mycbp -0.5236966 0.023238999
Sf3b4 -0.5257505 0.01150381
Gemin5 -0.5259505 0.012360708
Pno1 -0.5261394 0.005017275
Mrpl18 -0.5270604 0.007149373
Hspd1 -0.5276276 0.016206396
Phykpl -0.5278217 0.01967461
Nop58 -0.5278991 0.002640916
Hsp90aa1 -0.5285458 0.004559047
Klhl21 -0.5298036 0.020200454
Rspo3 -0.5305875 0.003677673
Magoh -0.5325781 0.021756697
Pfkp -0.5343331 0.037114187
Casc5 -0.5346706 0.010635018
Katna1 -0.5392394 0.040535413
Haus1 -0.5416084 0.018415097
Ddx20 -0.5419028 0.007250069
Zwilch -0.5423232 0.003516898
D8Ertd738e -0.5444438 0.036293603
Ppa1 -0.545403 0.048289851
Isoc1 -0.5481145 0.0163981
Lin28a -0.5484315 0.006155268
Cse1l -0.5488957 0.000267407
Lss -0.5497879 0.01150381
Mad2l1 -0.5499787 0.01318802
E2f4 -0.5500669 0.016680184
Cep76 -0.5505935 0.030346521
Noc3l -0.5510514 0.008931862
Rap1b -0.5510983 0.029783277
Ddx21 -0.551379 0.002062486
Zfp850 -0.5528011 0.034898561
Mrps22 -0.5561946 0.033198701
Ranbp1 -0.5567163 0.004602199
Umps -0.5584059 0.006954703
Dut -0.5585744 0.001840115
Mcm7 -0.5601798 0.000658803
Cep290 -0.5611988 0.0289515
Mif -0.5644379 0.022222952
Usp36 -0.5669756 0.029260583
Ppp1r14b -0.5692128 0.006049266
Hdgf -0.5709078 0.000333168
Hist1h1e -0.5717303 0.014219326
Cluh -0.5718228 0.010217169
Cks2 -0.5722872 0.037976577
Gcsh -0.5728595 0.001909046
Ahsa1 -0.574962 0.001385299
Pold1 -0.5749853 0.019814115
Sms -0.5751655 0.003849886
Jmjd6 -0.5756012 0.007296571
Fbl -0.5758456 0.00085362
Prps1 -0.5765977 0.040763638
Nop56 -0.5766727 0.037732378
Homer1 -0.5783565 0.035499608
Nhp2 -0.582946 0.00138054
Nasp -0.5832083 0.0001497
Noc2l -0.5835108 0.001151491
Rcc1 -0.5838483 0.01150381
Atad5 -0.5839931 0.000744992
Snrpd2 -0.5845768 0.049596743
Gsg2 -0.5887483 0.024804679
Mdk -0.5925585 0.036779379
Maz -0.5930999 0.031077508
Mrpl3 -0.5936589 0.010625531
Naf1 -0.5942042 0.005657614
Mid1 -0.5945538 0.010151093
Cenpn -0.5953636 0.007380439
Pprc1 -0.595594 0.010734992
Dis3 -0.5961683 0.000516827
Naa10 -0.5967393 0.014832121
Ankrd27 -0.5970243 0.036430871
Rpp14 -0.5981019 0.032039462
Gnl3 -0.6009705 0.004260171
Pa2g4 -0.6011336 7.33916E-05
Kmt2b -0.60144 0.035725263
Ddx39 -0.6014412 0.001368778
Nop10 -0.60184 0.006261636
Snapc4 -0.6024253 0.009725129
Sppl2a -0.6039032 0.01632944
Bop1 -0.6056497 0.006793952
Psat1 -0.6060635 0.00091311
E2f1 -0.6070543 0.01963896
Cap2 -0.6076249 0.000505951
Polr1b -0.6098149 0.002530932
Naa50 -0.6103831 0.027909075
Nup35 -0.6118891 0.038555559
Timeless -0.6145758 0.002158363
Pfas -0.616097 0.000899475
Rps12 -0.6173728 0.03182126
Aste1 -0.618063 0.031421462
Zmym1 -0.6181706 0.010592254
Dtymk -0.6182236 0.026420093
Kif15 -0.6183403 0.000279445
Haus3 -0.6188925 0.00930685
Mrpl52 -0.6198458 0.048700709
P2ry1 -0.6275068 0.026938192
Dusp18 -0.628064 0.012882798
Ccdc124 -0.6290632 0.02040009
Ell2 -0.6296718 0.018417458
Tk1 -0.6301929 0.037285962
Shmt2 -0.630889 7.98755E-05
Abcb10 -0.6330012 0.001300759
D030056L22Rik -0.6356704 0.018113235
Akt2 -0.6369274 0.021342939
L2hgdh -0.6389627 0.005507327
Rreb1 -0.6400927 9.95066E-05
Elac2 -0.6413754 0.002158363
Etl4 -0.6415104 0.001529963
2410002F23Rik -0.6417525 0.01963896
Nkrf -0.6418171 0.00353932
Mrpl47 -0.6420686 0.034731938
Lsm2 -0.6427002 0.012536752
9430015G10Rik -0.6469001 0.028851222
Uchl3 -0.6487112 0.008916301
Dhodh -0.6498502 0.024164708
Pole -0.6524743 0.001188025
Nmral1 -0.653271 0.046458929
Rad51 -0.653761 0.004066553
Urb1 -0.6553645 0.006278841
Mob1b -0.6574739 0.002452616
Nolc1 -0.6576932 8.64663E-06
Bckdhb -0.6580894 0.022112927
Bag2 -0.6645741 0.02505003
Smyd5 -0.6656635 0.026721458
Ndufs6 -0.6699754 0.015364912
Itga2b -0.6727368 0.020276582
Tsen2 -0.6775487 0.046466866
Edrf1 -0.6829337 0.00804993
Ppan -0.6850071 0.035644434
Ptgr1 -0.6889211 0.022856973
Cdc6 -0.6929623 0.001740874
3110082I17Rik -0.6937728 0.012238072
Diablo -0.6948298 0.029975046
Rybp -0.6951969 0.044775658
Dctd -0.7007772 0.002543299
Mob3c -0.7061391 0.029251299
Ippk -0.7063486 0.011952822
Rab11fip1 -0.7064745 0.00787161
Mrpl22 -0.7076716 0.018435039
Sod2 -0.7101316 0.00083047
Srxn1 -0.7117592 0.020276582
Tlcd1 -0.7161115 0.034951497
Mtrr -0.7165168 0.009427644
Uqcr10 -0.7168167 0.00711417
Heatr2 -0.7168978 0.006279683
Fancd2 -0.7181052 0.001233198
Tcof1 -0.718714 0.000177483
Trip13 -0.7194061 0.000102004
Rad54l -0.7201007 0.006443575
Rpp40 -0.720515 0.008722369
Tal1 -0.7243217 0.035004677
Ccdc18 -0.7250853 0.022430669
Zfp36l2 -0.7253139 0.001857072
Setd8 -0.7259416 0.000269964
Prkab1 -0.729529 0.000129675
Zbtb43 -0.7306579 0.038431642
Gins1 -0.7321125 0.009438331
Sf3b6 -0.7375405 0.022237244
Cep152 -0.7386925 0.035947492
Ung -0.7392586 0.016867812
Snrpa1 -0.741571 0.000208255
Slc16a6 -0.7451852 0.010050368
Ska3 -0.746177 0.005971886
Egln3 -0.7466605 4.23684E-05
Bcor -0.7480644 1.94473E-06
Zik1 -0.7482625 0.029931613
Srf -0.7496534 0.003480838
Snhg5 -0.7520657 0.000951237
Uqcr11 -0.7552484 0.01150381
Ddx11 -0.7563069 0.004176478
Psmc3ip -0.7568939 0.000419823
1110038B12Rik -0.7581591 0.001273613
Helb -0.7590714 0.020520561
Hsd17b7 -0.7599393 0.000674468
Prkcd -0.7609372 0.04692825
Smim3 -0.7616062 0.011321729
Notch2 -0.7648085 0.001607176
Hmgn2 -0.7648535 0.003655177
Lsm5 -0.7653828 0.020768793
Tfb2m -0.7675262 0.016153005
Anapc11 -0.7680224 0.034225692
Ppih -0.7682877 0.016367779
H2afx -0.7685989 0.000594153
Fancb -0.7713014 0.041391858
Gyk -0.7715793 0.046836397
Polr2i -0.7720022 0.01984889
Depdc1b -0.7720366 0.001707355
Zcchc10 -0.7745844 0.005241081
Snrpg -0.7818499 0.04215328
Klhl12 -0.7832182 0.001815011
E2f8 -0.78417 0.000180926
Epb4.1 -0.7849334 1.37786E-05
Wbscr16 -0.79124 0.018213973
Fth1 -0.7925434 0.000310477
Troap -0.7972141 0.023151903
Hspe1 -0.7988842 0.01963896
Rnd2 -0.8016923 0.022634645
Ern1 -0.8027457 0.004274098
Mtx3 -0.8052675 0.042241708
Suv39h2 -0.8053629 0.000264292
Tcf7 -0.8056699 3.70941E-05
Lyar -0.806388 5.67508E-06
Smtnl2 -0.8080904 0.013224797
Tnfaip8 -0.8116157 0.001896077
Peo1 -0.8136152 0.007218947
Speg -0.81617 0.021756697
Fut8 -0.8166749 0.000104545
D2Wsu81e -0.8168487 0.008155523
H2afz -0.8234957 3.07822E-08
Laptm5 -0.8267113 0.043365121
Ubxn2a -0.8271654 0.000222764
Stra13 -0.8316425 0.012298527
Rrp12 -0.8351638 0.000109874
Gcnt1 -0.8393189 2.35311E-05
Tsc1 -0.8417155 0.00012396
Trmt61a -0.8425698 0.000893326
Polr2f -0.8473131 0.007191282
Utp23 -0.8561307 0.010212308
Mrto4 -0.8586158 0.000100664
Fads2 -0.8661943 4.81338E-06
Tm7sf2 -0.8688088 0.025432283
Nbeal2 -0.8716841 0.006623268
Ska1 -0.8730391 0.036533027
Traip -0.8757748 0.020692508
Psph -0.8766564 0.006842544
Inip -0.8770961 0.001718342
Ormdl1 -0.8771678 0.00814927
Srl -0.8787499 0.023134393
C530008M17Rik -0.8817309 0.02435718
Hist1h1b -0.883334 5.46909E-05
Caprin2 -0.8843534 0.005657628
Rbmx -0.8861848 0.000459628
Grap2 -0.8868077 0.024330801
Sssca1 -0.8898676 0.000505951
Gas5 -0.8931038 0.001005654
Melk -0.8938092 0.000748058
Idi1 -0.8942903 0.000625845
Bcat1 -0.9044063 0.006141257
Mdm1 -0.9053117 7.9056E-05
Rps6ka6 -0.9072983 2.512E-06
Prmt1 -0.9141192 0.000276921
Fkbp11 -0.9174265 0.030220191
Slc19a1 -0.9234819 0.012924042
Ppil3 -0.9241589 0.033070183
Gtf3c5 -0.9250698 8.09209E-08
Hist1h2bb -0.9256411 0.034731938
Spc24 -0.9296335 9.00545E-05
Itga4 -0.9299064 0.000123511
Hist1h2be -0.9304375 0.022222952
Pola2 -0.9380601 1.61723E-05
Ahi1 -0.9508248 2.51545E-05
Acy1 -0.9528935 0.043805059
Ctla2a -0.9543965 0.049700762
Cenpp -0.9595026 0.01722529
Gpc6 -0.9623014 0.010298045
Shroom3 -0.9652569 0.038151613
Zfp692 -0.9781341 0.00385429
Tmem158 -0.9823048 0.025921359
Cited2 -0.9926737 1.75743E-06
Taf1d -0.9953624 0.036966046
Acot11 -1.0008928 0.00777375
Lsm7 -1.0009126 0.004305268
Slc7a5 -1.0036 2.17805E-06
Tmem86b -1.0039618 0.017467063
Ifi30 -1.0044766 0.048700709
Psd3 -1.0174544 0.03534982
Wdsub1 -1.0239369 0.048950469
1810032O08Rik -1.0328231 0.029931613
Hist1h4d -1.0383794 0.005507327
Dctpp1 -1.0393153 0.000317381
Plscr1 -1.039389 0.004614916
Pmp22 -1.0535001 0.009847584
Mgat4a -1.0568436 0.007776813
C77080 -1.0585692 0.000189306
Snhg3 -1.0648738 0.010269121
Sec61g -1.0666418 0.017108692
Psmg4 -1.0676331 0.046324916
Sdc1 -1.0753188 0.000999753
Fzd2 -1.0778418 0.027968234
Lhpp -1.0879831 0.02047849
Gse1 -1.0939363 2.31344E-11
Zfp930 -1.0940181 0.000645702
Lsm3 -1.0963022 0.004523766
Tagln -1.1030145 0.034761101
Car2 -1.1035294 0.035986008
Kcnj5 -1.1045913 0.000544414
Med30 -1.1093461 0.019362238
Dsp -1.1110028 0.009917825
Lpar1 -1.1156382 0.033861499
Kalrn -1.1171644 1.07783E-06
Ccdc134 -1.1231804 0.020684784
Xk -1.1366802 0.007849919
Dyrk2 -1.1426776 0.009743851
Irs1 -1.1430887 0.002965951
Kctd15 -1.1434019 0.028175567
Lyl1 -1.1442502 0.000958535
Apitd1 -1.1442509 0.00232128
Ank3 -1.1478545 5.47484E-07
Etv2 -1.1482494 0.003357049
Arhgap6 -1.1576452 1.26249E-05
Tpm2 -1.1599192 0.005227615
Cth -1.1612232 0.032836443
Mtfp1 -1.162728 0.010298045
Chchd1 -1.1640701 0.042687922
Fam109b -1.1687442 0.034422349
Snrnp25 -1.1795927 8.64663E-06
Tfrc -1.1817508 1.42962E-15
Fzd10 -1.1850427 0.012027882
Robo2 -1.1976152 0.027968234
Rab27b -1.2026754 0.000262575
Hist1h3e -1.207497 0.002028412
Hist1h2bm -1.2087727 0.000166046
Pde4dip -1.2117548 2.22157E-08
Myl9 -1.2154017 0.008966617
Col5a1 -1.2365169 0.024124732
Nfix -1.2439774 0.028851222
Plek -1.2460721 0.029677111
Hist1h2ac -1.2654033 0.048005393
Sh3bp1 -1.2655429 3.82269E-06
Slc35f2 -1.2714037 0.004479282
Med12l -1.2776314 5.18855E-08
Eno3 -1.2819185 0.00053602
Gria2 -1.2929235 0.012739783
Prtg -1.2975163 3.8001E-10
Samd14 -1.3126027 0.034398076
Gfra2 -1.3188517 0.001212132
Hist2h2ac -1.3249293 0.043805059
Hist1h2bl -1.3323982 3.94278E-06
Hist1h4c -1.3424522 0.036779379
Lgals9 -1.3443204 0.001153782
Phgdh -1.3465429 1.0238E-06
Hist1h4a -1.3568512 0.040921913
Hspb8 -1.3581106 0.047653617
Hist1h2bf -1.3608963 9.84748E-05
Lama1 -1.3748046 0.010539709
Ptpre -1.3799639 6.33328E-07
Mpl -1.383543 0.00145656
Gfi1 -1.3873919 0.029781297
Tenm3 -1.3946725 0.036732568
Klf8 -1.398728 1.0931E-09
Cyp26b1 -1.4037073 0.010353402
Hist1h2ak -1.4072807 0.000275295
Pitx2 -1.410157 0.003136119
Dyrk3 -1.4106397 0.004579839
Nap1l2 -1.4284217 0.041255062
Ston2 -1.4291669 0.000106664
Hist1h3g -1.4334317 0.001909046
Ifitm1 -1.4344149 5.82107E-05
Adamts9 -1.4390785 0.020080206
Mrvi1 -1.439407 0.0163981
Sfrp2 -1.4502113 0.034731938
Lrr1 -1.45511 0.004465313
Mpo -1.4663655 0.01179793
Ryr2 -1.4690604 0.016935002
Unc5c -1.4771939 4.14642E-15
Egfl8 -1.4885643 0.048391189
Fam117a -1.4937007 0.00425314
Hist1h2bh -1.4980855 4.37625E-05
Syt7 -1.5153341 0.017781453
Gpc3 -1.5323008 7.16894E-09
Sall3 -1.5370094 1.50775E-17
Wnt5a -1.5468432 0.000760804
Hist1h3i -1.5483412 0.026721458
Plcxd1 -1.5523584 0.038153598
Hist1h2bp -1.5681605 0.009899788
Hist1h2bk -1.5735921 0.00043405
Snord99 -1.5909402 0.016290154
AI467606 -1.5969964 0.022946391
Ptprj -1.6077737 1.0931E-09
Ctse -1.6078993 0.002431662
Prkca -1.6098811 3.36158E-10
Rgs10 -1.6222642 0.013254674
Wisp1 -1.63618 0.000674468
Hist1h1a -1.6408645 0.00010791
Dlg3 -1.6444894 0.038467385
Krt19 -1.6450808 0.004714719
Pappa -1.6741823 0.020220736
Cnn1 -1.6778678 0.028766399
Dapp1 -1.7240331 1.26418E-07
Ccnd2 -1.7249129 8.48488E-05
Sdc2 -1.7252224 0.001295174
Slc30a3 -1.7763864 0.020783337
Hist1h2ai -1.8043194 0.048613885
Nrgn -1.8055743 0.009964598
Aif1l -1.8075623 0.000117149
Atp2a3 -1.8125327 2.57553E-06
Rps6kl1 -1.8244938 0.049403296
Gm16982 -1.848031 0.031813334
Tmem62 -1.8548086 0.013302571
Thsd4 -1.867671 0.002237663
Col1a2 -1.8752501 0.000867063
Kcnj2 -1.8778166 0.009381743
Itgb3 -1.904678 1.03962E-06
Snord47 -1.908005 0.035065481
Hist1h4k -1.9096921 0.00594326
Gng7 -1.9207414 0.01967723
Ackr3 -1.9236598 0.001112783
Fam46a -1.9265152 0.007309261
Cdh11 -1.9347074 0.003681232
Acta2 -1.9431264 0.001082949
Igsf11 -1.9730923 0.0032421
Hbb-y -1.9748359 4.58395E-05
Ubxn11 -1.983615 0.006842544
Ikzf2 -1.9955979 8.66601E-16
Epcam -1.9977628 0.010155013
Was -1.9990616 8.50094E-05
Acat3 -2.0060747 0.027344644
Mcoln3 -2.0135873 0.03269587
Hist1h4j -2.0168569 0.037114187
Gli2 -2.0256238 0.001703197
Smyd1 -2.0480579 0.018380174
Pde11a -2.0583309 0.028033733
Map7d2 -2.0666869 0.032464685
Wwc1 -2.0764389 0.000471852
Hba-x -2.0906682 3.15899E-07
Irs2 -2.0961118 5.87776E-20
Pdgfrb -2.1019287 0.007434748
Ptpn13 -2.1059753 4.78986E-08
Nfe2 -2.1065983 4.46548E-08
Smim1 -2.1151748 0.014903031
Fgf10 -2.1307131 1.51684E-05
Wnt4 -2.1362897 0.001401918
Snord15b -2.157675 0.00934557
Sytl5 -2.1590435 0.000440282
Syne4 -2.1602438 0.006038733
Lrp2 -2.1683193 0.000121691
Kcnd3 -2.1909069 0.006903889
Kif26b -2.2020228 0.034731938
Tspan32 -2.2086198 8.02448E-06
Gfi1b -2.2107003 1.69686E-06
Cgn -2.2139564 0.002217795
Chpf -2.2346358 0.021439509
Col12a1 -2.2377922 1.30785E-05
Mir1949 -2.252971 0.006517304
Reep6 -2.2591005 0.000441881
Gucy1a3 -2.2596713 3.05581E-09
Fam110c -2.2660124 0.047497123
Pkd1l3 -2.2721338 0.024648589
Col8a1 -2.275621 0.004586186
Ikzf1 -2.2786084 1.54656E-16
Phlda2 -2.2808251 0.000544414
Sdk2 -2.3005852 0.001789848
Cort -2.3033757 0.043196035
F3 -2.3463844 0.002491942
Ildr2 -2.3554778 0.025410734
Cnksr2 -2.4145604 0.001740874
Adamts3 -2.4415041 1.14347E-16
Slit3 -2.4443195 0.016761722
Ccl17 -2.4618337 0.005656976
Scube2 -2.4633338 1.24981E-05
P2rx1 -2.4648688 4.24094E-06
Plbd1 -2.4842592 0.043805059
Nog -2.4867721 0.030749983
Evx1 -2.5070756 0.00710432
Pard6b -2.5132174 7.02155E-11
Dlk1 -2.5174664 0.011179574
Lypd6 -2.527006 0.012079092
Slc16a10 -2.5476922 1.04806E-05
Igfbp2 -2.5554076 1.85263E-05
Epb4.2 -2.5598202 1.80207E-05
Krt8 -2.5741038 1.01582E-06
Terc -2.5834174 0.019295424
Hoxd1 -2.621979 8.15008E-07
Myl4 -2.630741 0.007701513
5330426P16Rik -2.6446846 0.028999329
Adamts15 -2.6619076 0.001835464
Klhl34 -2.6888257 0.024330801
Snord65 -2.6966047 0.013699384
Zic3 -2.7075066 0.010077455
Chac1 -2.7158122 0.03425189
Car12 -2.7161838 0.0125579
Runx1 -2.7256084 1.65762E-27
Gpr56 -2.7306544 6.13521E-12
Lypd1 -2.7503944 0.029587149
Bdnf -2.7569741 0.017067973
Cemip -2.7597959 0.009725129
Psd2 -2.7685594 0.040231909
Bhlhe22 -2.7788676 0.045899837
Nkx1-2 -2.8116603 4.82819E-06
Krt18 -2.8300695 1.94958E-05
Fgf15 -2.8448297 0.000744992
Ripk4 -2.8502852 0.035644434
Acta1 -2.8507773 0.006706841
Mfsd2b -2.8581726 3.30438E-10
Hbb-bh1 -2.8585705 2.13735E-10
Nnat -2.870562 0.009436605
1700024P16Rik -2.9094172 0.046185933
Treml2 -2.9188545 0.016448242
Il18rap -2.9367721 0.025586714
Cdh22 -2.9609251 0.04793262
Lgr5 -2.9755872 4.11712E-26
Rgs4 -3.045216 0.004274047
Bmp8a -3.0462458 0.000513324
Enpp1 -3.0546272 4.11656E-06
Asic4 -3.0661955 0.008931862
Col11a2 -3.1009018 0.026664828
Igfbp5 -3.1027981 5.0016E-11
Scube3 -3.1383901 0.00062887
Crabp2 -3.2575996 0.006155268
Kcnk1 -3.2686447 3.72197E-05
Rpph1 -3.281995 2.1394E-05
Lmod1 -3.2934985 0.027317316
Cacna1d -3.3339941 0.015484623
Dpf3 -3.3366168 0.00736531
Gm14204 -3.3480536 0.003222281
Cdh3 -3.3515719 4.85866E-06
Svep1 -3.3665107 0.024600296
Plac8 -3.3850148 0.035162852
Ppp1r14a -3.3875344 0.02733033
Snord11 -3.4033326 0.03447524
Col2a1 -3.4043366 0.007702911
Krtap5-4 -3.4274958 0.013850109
Tenm4 -3.4333517 0.000392286
Postn -3.4429613 8.23112E-10
Myb -3.4543925 8.33645E-09
Inhba -3.4548191 0.000713988
Tgfb3 -3.4614945 0.004896411
Slc32a1 -3.4787561 0.01146119
Twist2 -3.486109 0.013411972
Vgll3 -3.5369871 4.22616E-07
Actc1 -3.5579124 7.50346E-08
Bnc2 -3.5880639 0.009472726
Reln -3.6170028 3.50005E-25
Krt14 -3.6405079 0.039694071
Sycp2 -3.6541894 0.034731938
Olfr893 -3.6656714 0.044066221
Col1a1 -3.6976688 4.95442E-05
Slc7a8 -3.7032242 5.53584E-19
Snord49b -3.7060819 0.016344227
5830432E09Rik -3.7217186 0.018434404
Mir3473 -3.7421314 0.043179572
1700019A02Rik -3.8088791 0.011713162
Loxl1 -3.8129879 0.000497308
Mfap4 -3.8436132 1.62745E-06
Slc14a1 -3.9021836 0.032075036
Ms4a4d -3.9106388 0.009878012
Arpp21 -3.9845324 0.013484556
Tuba8 -4.0014776 0.004465313
B4galnt3 -4.0405548 0.017018905
Mir1188 -4.0457792 0.047141713
Cbln1 -4.0779217 1.74552E-06
Bzrap1 -4.0941697 0.025511069
Mycbpap -4.1183436 0.013319538
Tacstd2 -4.1381791 0.016813797
Mir6516 -4.1802058 0.000180383
Nrip3 -4.2215567 6.59402E-12
Pdzk1ip1 -4.2568504 4.63652E-06
Ajap1 -4.2816439 0.043805059
Ccl3 -4.4113143 0.007390122
Muc13 -4.4403089 4.55768E-05
Cobl -4.4440277 0.012298527
Dlx5 -4.4620843 0.022676496
Col8a2 -4.5076296 0.028016048
D830026I12Rik -4.542468 0.00273577
Smoc2 -4.5827836 0.049940314
Mir6940 -4.5833125 0.020094533
Sema5b -4.5908909 0.000185175
Ndufa4l2 -4.6090649 0.00112525
Slc1a6 -4.6456547 0.001159997
Pgm5 -4.6485806 0.026721458
Gabra4 -4.7118276 0.042610543
Alx3 -4.8471877 0.01150381
A4gnt -5.1071371 0.03788653
Vat1l -5.1080698 0.0032421
Slitrk2 -5.1635952 0.004155895
Pip5kl1 -5.1675678 0.014014826
Mir1940 -5.2146295 0.036533027
Dppa5a -5.2384808 2.24686E-06
Tph1 -5.285813 0.017552353
Bmp7 -5.3633196 0.00053602
Atp6v0d2 -5.5623301 0.000386004
Pitx1 -5.5980066 0.013302571
Olfml1 -5.6903819 0.001273613
Prr15l -5.7339197 0.017886152
BC027072 -5.7931802 0.011830787
Zfp641 -5.8463841 0.048973333
Gata1 -5.9307033 1.14278E-08
Fgf3 -5.9991188 1.15752E-07
Rnase6 -6.0909008 0.04215328
Lum -6.1112301 0.020767104
Vmn2r2 -6.1502481 0.026296039
Atp6v0a4 -6.270693 0.024844203
Clec18a -6.5983151 3.59311E-05
Elfn2 -6.6897525 0.001713009
Cd164l2 -7.1662694 0.003073471
Wfdc17 -7.1680774 0.000253078
Fstl3 -7.2822667 0.001909046
Tmem54 -7.5876681 0.000153509
Orm1 -7.628743 0.000867063
Sema4f -8.0860262 0.002174643
